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INTRODUCTION
Pfizer’s Chinese patent for Viagra was issued in late 2001.1
Shortly thereafter, a number of Chinese companies filed requests in
China’s State Intellectual Property Office (SIPO) to invalidate the
patent.2 Viagra, one of the most successful prescription drugs ever
launched in the United States, generates about one and a half
billion dollars of annual sales in the U.S.3 With China’s market
size, patent protection for Viagra in China means millions of
dollars for Pfizer. Because of the high stakes involved, this case
took much longer time than usual.4 Finally, in early July 2004, the
Patent Reexamination Board of SIPO declared the Chinese patent
for Viagra invalid.5 Pfizer was “extremely disappointed” with this
decision6 and has filed an appeal to the People’s Court.7
The protection of intellectual property rights (IPR) in China
has been an important issue for foreign companies that want to tap
into China’s vast market, as well as for IPR holders in China. The
still relatively underdeveloped Chinese legal system and the lack
of transparency in the legal proceedings are sources of concern for
IPR holders. In China, a civil law country, court decisions

1

See Liu Li, Patent on Viagra Faces Challenge, China Daily (Sept. 29, 2004), at
http://www.chinadaily.com.cn/english/doc/2004-09/29/content_378513.htm.
2
Press Conference, Jing-chuan Wang, Director of SIPO (China Central Television
(CCTV-9) broadcast, Apr. 12, 2004) (on file with author).
3
See, e.g., Al Branch, Jr., Competition for Viagra, PHARMACEUTICAL EXECUTIVE, at
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=36725 (Nov. 1, 2002).
4
Wang, supra note 2.
5
See Guo Nei, Viagra Patent Found Invalid, China Daily (July 9, 2004), at
http://www.chinadaily.com.cn/english/doc/2004-07/09/content_346788.htm.
6
See Intell. Prop. L. Bull., Pfizer, Trade Group Protest China’s Overturn of Viagra
Patent (July 19, 2004), at http://www.iplawbulletin.com/cgi-bin/absolutenm/anmviewer.asp?a=1780.
7
See Nicole Ostrow, Pfizer Appeals China’s Decision to Overturn Patent on Viagra,
NEWS
SERVICE,
at
http://quote.bloomberg.com/appsBLOOMBERG
/news?pid=10000087&sid=aEFUVtf_a498&refer=top_world_news (Sept. 28, 2004).
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generally have no binding authority8 and are not regularly
published as legal documents.9
After China’s entry into the World Trade Organization (WTO)
on December 11, 2001,10 however, China is expected to play by
the WTO rules regarding IPR, mainly the Trade-Related Aspects
of Intellectual Property Rights (TRIPS).11 One of the TRIPS
requirements is that the resolution process of IPR disputes be
transparent.12 On November 5, 2003, the Beijing High People’s
Court, in a dramatic move, started to make available on the
Internet judicial decisions on IPR cases handled by courts at
various levels in Beijing.13 As of March 2004, more than 300
8

See Tianjin Court Issues China’s First Legal Precedents, XINHUA NEWS AGENCY, at
http://www.china.org.cn/english/2003/Aug/71445.htm (Aug. 1, 2003). But as China’s
Xinhua News Agency reported, the Higher People’s Court of Tianjin, in a historical
move, had issued three cases to which lower courts can refer in making judgments. This
is the first time a Chinese higher court has issued legal precedents. Id.
9
The Supreme People’s Court, the highest court in China, publishes some of its
judgments in the Supreme Court Gazette. These judgments have no binding authority.
However, there presently is a tendency in China to try to give them some binding
authority, largely as a result of the criticism of the inconsistency of courts’ statutory
interpretations. Email to the author from Hon. George Q. Fu, Managing Partner, Watson
& Band Law Offices, Shanghai, China (Feb. 4, 2004) (copy on file with author).
10
See Members and Observers, at http://www.wto.org/english/thewto_e/whatis_e/tif_e/org6_e.htm (last visited Oct. 22, 2004).
11
See
generally
Frequently
Asked
Questions
about
TRIPS,
at
http://www.wto.org/english/tratop_e/trips_e/tripfq_e.htm#Who’sSigned (last visited Oct.
22, 2004) (stating that the TRIPS agreement applies to all WTO members).
12
See Agreement on Trade-Related Aspects of Intellectual Property Rights, Apr. 15,
1994, Marrakesh Agreement Establishing the World Trade Organization, Annex 1C,
LEGAL INSTRUMENTS—RESULTS OF THE URUGUAY ROUND vol. 31, 33 I.L.M 81 (1994) pt.
V, art. 63(1), available at http://www.wto.org/english/tratop_e/trips_e/t_agm0_e.htm
(last visited Oct. 22, 2004) [hereinafter TRIPS Agreement]. “Laws and regulations, and
final judicial decisions and administrative rulings of general application, made effective
by a Member pertaining to the subject matter of this Agreement (the availability, scope,
acquisition, enforcement and prevention of the abuse of intellectual property rights) shall
be published, or where such publication is not practicable made publicly available, in a
national language, in such a manner as to enable governments and right holders to
become acquainted with them.” Id.
13
See Court Decisions Go Online in Beijing, XINHUA NEWS AGENCY, at
http://www.china.org.cn/english/government/79383.htm (Nov. 6, 2003). All of the
judicial documents of the first and final judgments on IRP cases will be uploaded to the
website http://bjgy.chinacourt.org. Id. Confidential information or trade secrets that form
part of the evidence of the IPR proceedings, however, are likely not to be published, in
keeping with China’s Civil Procedure Law. See art. 66 of the Civil Procedure Law of
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court decisions have been posted on that website, including patent,
trademark, copyright, unfair competition, and technology contract
cases.14 Among the patent cases posted, about 50% are appeals of
patent invalidation decisions by the Patent Reexamination Board of
SIPO.15
With this new development, it is likely that the final decision
on Pfizer’s appeal of the invalidation of the Viagra patent will be
posted on the Internet, and one can examine it to see whether the
interests of Pfizer (and those of the Chinese companies) are fairly
protected. Until the case is published, however, the reader may
wonder: On what grounds can a person file a request for
invalidation of a patent in China?16 More generally, what is the
law and practice like in China regarding post-grant patent
invalidation? What are the differences and similarities between
China’s patent invalidation proceeding and those of the United
States, Europe and Japan?17 Why do we need a post-grant patent
China (English translation), available at http://www.enonline.sh.cn/ILlook.asp?id=10285
(last visited June 20, 2004).
14
See http://bjgy.chinacourt.org/cpws/index.php (last visited Nov. 19, 2004).
15
See id. Readers familiar with the lack of usage of the American post-grant
reexamination proceedings, might ask why China’s patent invalidation procedure is so
frequently used—50% of the courts’ cases are about appeal of invalidation decisions? In
reality, the frequency of usage is much lower. See infra Part II.G. The high percentage is
due to the fact that the Beijing Intermediates Courts are the designated courts for appeals
of SIPO invalidation decisions. See infra notes 56–57 and accompanying text.
16
It is not clear on exactly what grounds the Chinese companies had challenged the
Viagra patent, but according to a leading official at SIPO, the patent had insufficient
technological disclosure. See Intell. Prop. L. Bull., China Defends Decision to Revoke
Viagra
Patent
(Sept.
7,
2004),
at
http://www.iplawbulletin.com/cgibin/absolutenm/anmviewer.asp?a=2109&z=13. Such a ground, which largely relates to
the written description and/or enablement requirements in the United States, would not
have been a valid ground for invalidating a patent in the United States, where the
patentability issues considered during reexamination are typically limited to novelty and
obviousness. See infra notes 265, 335 and accompanying text; see also infra Part II.B for
more details about the grounds for invalidation in China, which are broader than in the
United States.
17
The law regarding post-grant patent invalidation, also known as opposition,
reexamination, or revocation proceedings—depending on the country—has been very
much in flux in recent years. The United States, Japan, and China all amended relevant
patent invalidation procedures in recent years. See infra Parts II–III. In the United States,
there are ongoing discussions of reform. See generally Fed. Trade Comm’n, To Promote
Innovation: The Proper Balance of Competition and Patent Law and Policy 4, at
http://www.ftc.gov/os/2003/10/innovationrpt.pdf (Oct. 2003) [hereinafter FTC Report];
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invalidation system, and what essential features should a good one
have? This paper attempts to address these questions. A better
understanding of the Chinese Patent Invalidation proceeding,
particularly in comparison with the counterpart proceedings of the
major Western countries, should help multinational companies like
Pfizer to better protect their patent rights in China by adopting
appropriate patent procurement and protection strategies.
Part I of this paper provides as background a brief account of
the development of IPR protection in China, particularly patent
protection. In Part II, the patent invalidation procedure in China is
discussed. Part III introduces the patent invalidation systems in the
trilateral patent offices of Japan, the European Patent Convention
(“EPC”), and the United States. In Part IV, a brief discussion of a
desirable post-grant invalidation system is presented, followed by a
comparison of several key features of the Chinese system with
their counterparts in the trilateral offices.
I. PATENT LAW DEVELOPMENT IN CHINA AFTER 1978
This section first briefly discusses the history of IPR legislation
in China. It then introduces the Chinese Patent Law, particularly
the patentability provisions, which are important to the discussion
of the Chinese patent invalidation system in Part II. Finally, this
section discusses the channels available for IPR dispute resolution
in China, including the jurisdiction for patent invalidation
proceedings.
A. Brief History of IPR Legislation in China
Over its long history, China did not develop a sustained
indigenous intellectual property protection system, partly due to
the character of its political culture, despite the fact that China’s
civilization was, for centuries, one of the world’s most
sophisticated, culturally, scientifically, and technologically.18
Mark D. Janis, Rethinking Reexamination: Toward a Viable Administrative Revocation
System for U.S. Patent Law, 11 HARV. J.L. & TECH. 1 (1997).
18
See WILLIAM P. ALFORD, TO STEAL A BOOK IS AN ELEGANT OFFENSE: INTELLECTUAL
PROPERTY LAW IN CHINESE CIVILIZATION 2–3 (1995).
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Attempts at the turn of the twentieth century to introduce European
and American intellectual property law to China were
unsuccessful.19 After its founding in 1949, the People’s Republic
of China (PRC) began to establish an intellectual property
protection regime based on the Soviet model.20 The fledgling
intellectual property laws, however, were decimated, together with
the entire legal system, by the Cultural Revolution of 1966–1976.21
In 1978, China adopted the open-door policy.22 The next
twenty years witnessed a dramatic cultural, economic, and political
transformation in the Chinese society, as well as “a remarkable
burst of legislative activity.”23 Today, some of China’s laws,
including intellectual property (IP) laws, are rather close to those
of developed Western nations.24 China has promulgated a full
spectrum of IP-related laws and regulations, including, inter alia,
Patent Law, Trademark Law, Copyright law, and Law Against
Unfair Competition.25 These specific IP laws, together with the
Constitution, the General Principles of Civil Law, the Civil
Procedure Law, the Criminal Law, etc., form a complete system of
IPR protection in China.26
B. The Patent Law of China; Patentability Requirements
The Patent Law of China (“Patent Law”) was first promulgated
on March 12, 1984.27 It has since undergone two major revisions:
19

See id.
See id. at 56–63.
21
See id. at 63–65.
22
See
Center
for
International
Development,
China
Summary,
at
http://www.cid.harvard.edu/cidtrade/gov/chinagov.html (last updated Jan. 2004).
23
See, e.g., Jerome A. Cohen, The Chinese Legal System: A Primer for Investors, 17
N.Y.L. SCH. J. INT’L & COMP. L. 345, 346–47 (1997).
24
See generally Michael N. Schlesinger, Intellectual Property Law in China: Part I—
Complying with Trips Requirements, 19 NO. 1 E. ASIAN EXECUTIVE REP. 9 (1997)
(stating that “China is in substantial compliance with the TRIPS provisions on
trademarks, patents and copyrights . . . .”).
25
See, e.g., Ping Zhang, The Development of China’s Intellectual Property Protection
System, CASRIP NEWSLETTER (Center for Advanced Study and Res. on Intell. Prop.,
Seattle, WA.), Spring/Summer 1998, at http://www.law.washington.edu/casrip/newsletter/newsv5i2zhang.html.
26
Id.
27
See State Intell. Prop. Office of the P.R.C., Patent Law of the People’s Republic of
China,
http://www.sipo.gov.cn/sipo_English/flfg/zlflfg/t20020327_33872.htm
(last
20
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the first was in 1992,28 and the second in 2000.29 Implementing
regulations were also promulgated.30 Among China’s IP laws, the
Patent Law is considered the closest to being in complete
compliance with TRIPS; any deviations are relatively minor.31
Under the current Patent Law of China, there are three types of
patents: patents for inventions, utility models and designs.32
According to the Implementing Regulations of the Patent Law
(“Implementing Regulations”), “invention” means any new
technical solution relating to a product, a process or improvement
thereof;33 “utility model” refers to any new technical solution
relating to the shape, structure, or combination thereof, of a
product that is fit for practical use;34 and “design” refers to any
new design of the shape, pattern, color, or a combination thereof,
of a product, which creates an aesthetic feeling and is fit for
industrial application.35

amended Aug. 25, 2000) [hereinafter Chinese Patent Law]. The author would like to
caution the reader that the English translations of Chinese laws, including but not limited
to IPR-related laws, which are available in books or on the internet, often contain
inaccuracies or even mistakes, and therefore do not always accurately reflect the original
meaning of the laws. The reader is strongly advised not to rely solely on these English
translations as legal authority in “real-life” situations, but to obtain advice from counsel
well-versed in the relevant laws.
28
See Decision of the Standing Comm. of the Nat’l People’s Cong. on Amending the
Patent Law of the People’s Republic of China, Laws of the People’s Republic of China
1990–1992, Science Press, 1993, 501–18. The amended law became effective January 1,
1993. See id.
29
For an English translation of the current Patent Law of China, see Chinese Patent
Law, supra note 27.
30
See State Intell. Prop. Office of the P.R.C., Implementing Regulations of the Patent
Law of the People’s Republic of China, http://www.sipo.gov.cn/sipo_English/flfg/zlflfg/t20020327_33871.htm (effective July 1, 2001) [hereinafter Implementing
Regulations].
31
See Schlesinger, supra note 24, at 13–14 (“China has made great progress in recent
years in creating a modern patent regime, one that both conforms with international
intellectual property norms and complies with most of the major provisions of TRIPS on
patents.”).
32
See Chinese Patent Law, supra note 27, art. 2 (“In this Law, ‘inventions-creations’
mean inventions, utility models and designs.”).
33
Implementing Regulations, supra note 30, Rule 2(1).
34
Id., Rule 2(2).
35
Id., Rule 2(3).
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Regarding patentable subject matter, Article 5 of the Patent
Law stipulates that “[n]o patent right shall be granted for any
invention-creation that is contrary to the laws of the State or social
morality or that is detrimental to public interest.”36 Also, no patent
right shall be granted for any of the following: (1) scientific
discoveries; (2) rules and methods for mental activities; (3)
methods for the diagnosis or for the treatment of diseases; (4)
animal and plant varieties; (5) substances obtained by means of
nuclear transformation.37
Regarding the basic requirements for the grant of patent right
for an invention or utility model, Article 22 of the Patent Law
provides:
Any invention or utility model for which patent right[s]
may be granted must possess novelty, inventiveness and
practical applicability.
Novelty means that, before the date of filing, no identical
invention or utility model has been publicly disclosed in
publications in the country or abroad or has been publicly
used or made known to the public by any other means in
the country, nor has any other person filed previously with
the Patent Administration Department Under the State
Council an application which described the identical
invention or utility model and was published after the said
date of filing.
Inventiveness means that, as compared with the technology
existing before the date of filing, the invention has
36

Chinese Patent Law, supra note 27, art. 5. Similar provisions are found in EPC,
infra note 194, art. 53:
Exceptions to patentability: European patents shall not be granted in respect of:
(a) inventions the publication or exploitation of which would be contrary to
‘ordre public’ or morality, provided that the exploitation shall not be deemed to
be so contrary merely because it is prohibited by law or regulation in some or
all of the Contracting States;
(b) plant or animal varieties or essentially biological processes for the
production of plants or animals; this provision does not apply to
microbiological processes or the products thereof.
37
Chinese Patent Law, supra note 27, art. 25. But processes used in producing animal
and plant varieties may be patentable. See id; see also EPC, infra note 194, art. 52.
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prominent substantive features and represents a notable
progress and that the utility model has substantive features
and represents progress.
Practical applicability means that the invention or utility
model can be made or used and can produce effective
results.38
These requirements for patentability largely correspond to the
U.S. requirements for novelty, non-obviousness, and utility,39 as
well as the EPO requirements of novelty, inventive step, and
industrial applicability.40
The Patent Law has a special provision, in Article 24, for a sixmonth grace period with respect to novelty, specifying three
particular situations where the novelty of the patent application
would not be affected:
An invention-creation for which a patent is applied for does
not lose its novelty where, within six months before the
date of filing, one of the following events occurred:
(1) where it was first exhibited at an international
exhibition sponsored or recognized by the Chinese
Government;
(2) where it was first made public at a prescribed
academic
or
technological
meeting;
(3) where it was disclosed by any person without the
consent of the applicant.41

38

Chinese Patent Law, supra note 27, art 22. With regard to the patentability of a
design, Article 23 of the Patent Law provides that: “Any design for which patent right[s]
may be granted must not be identical with and similar to any design which, before the
date of filing, has been publicly disclosed in publications in the country or abroad or has
been publicly used in the country, and must not be in conflict with any prior right of any
other person.” Id. art. 23.
39
See 35 U.S.C. §§ 101–103 (2003). The United States provides a one-year grace
period for the application after certain publication or disclosure of the invention. See id.
§ 102(b); cf. infra note 41 and accompanying text.
40
See EPC, infra note 194, arts. 54–56. A key difference is, of course, that the EPC
does not provide for a six-month grace period. See infra note 41 and accompanying text.
41
Chinese Patent Law, supra note 27, art. 24.
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Although this six-month grace period allows for the retention
of novelty despite the disclosure of the invention in the three
specified situations, the date of such disclosure does not constitute
priority for a patent application claiming the disclosed invention.42
Thus, if following an Article 24 disclosure, but before the inventor
files a patent application over the disclosed invention, a third party
independently files a patent application over the same invention,
the “first-to-file” principle43 dictates that the inventor cannot obtain
a patent.44 But the third party cannot obtain a patent either,
because due to the Article 24 disclosure, the third party’s
application lacks novelty.45
C. Channels for IPR Dispute Resolution in China
In China, IPR can be enforced both through administrative
authorities and through the courts.46 The Patent Law, Trademark
Law and Copyright Law of China all provide Chinese
administrative authorities with the power for IPR enforcements.47
In a case of patent infringement, administrative authorities may,
sometimes ex officio, order an infringer to cease the infringing
action and pay damages.48 Alternatively, a party whose patent has
been infringed may sue the infringer directly in the People’s
42

See SIPO Guidelines for Patent Examination (hereinafter Guidelines), pt. II, ch. 3, §
5.4. This is the “MPEP” of China (“MPEP” is the Manual of Patent Examining
Procedures of the United States Patent and Trademark Office). The Guidelines embody
the Patent Law and its Implementing Regulations, and are the basis for the Patent Office
and the Patent Reexamination Board—two parallel and independent branches under the
SIPO—to exercise their power. The Guidelines has been translated into English by
Helen Han of NTD Patent & Trademark Agency Limited, in THE GUIDELINES FOR
PATENT EXAMINATION (2001), ISBN 962-7006-58-0.
43
See Chinese Patent Law, supra note 27, art. 9 (“Where two or more applicants file
applications for patent for the identical invention-creation, the patent right shall be
granted to the applicant whose application was filed first.”).
44
See Guidelines, supra note 42, pt. II, ch. 3, § 5.4.
45
See id.
46
See Michael N. Schlesinger, Intellectual Property Law in China: Part II—Evolving
Judicial Role in Enforcement, 19 NO. 3 E. ASIAN EXECUTIVE REP. 9, 9 (1997).
47
See Chinese Patent Law, supra note 27, art. 57; Trademark Law of China, art. 41,
available at http://www.sipo.gov.cn/sipo_English/flfg/default.htm (last visited Oct. 26,
2004); Copyright Law of China, art. 47, available at http://www.sipo.gov.cn/sipo_English/flfg/default.htm (last visited Oct. 26, 2004).
48
See Schlesinger, supra note 46, at 11 (citing Chinese Patent Law, art. 60).
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Courts.49 However, as detailed in Part II below, interested parties
who want to challenge the validity of a patent must initiate the
challenge through the patent invalidation procedure in SIPO.
While historically administrative enforcement has played a
more important role than judicial proceedings in resolving IPR
disputes in China, the balance is gradually shifting.50 In July 1993,
the Chinese government took an unprecedented step and
established specialized IP divisions in the People’s Courts.51
Currently, IP cases in China are largely handled by thirty-one
Higher Courts and just over 300 Intermediate Courts around
China.52 The No. 3 Civil Division of the Supreme People’s Court
is the highest IP trial organ in China.53

49
See Chinese Patent Law, supra note 27, art. 57. Criminal sanctions are also available
in China for IPR infringement. The Criminal Law of China provides seven counts of IP
criminal offenses. See generally Schlesinger, supra note 46; see also Fu, infra note 52, at
4. Article 58 of the Patent Law provides that parties passing off another’s patented
product as their own may be prosecuted under the Criminal Law, potentially leading to
imprisonment, criminal detention, or criminal fines. See Chinese Patent Law, supra note
27, art. 58. In the two years from April 2001 to March 2002, Chinese courts took up 851
IP criminal cases, implicating 1288 individuals. During the same period, 775 criminal
cases were finally adjudicated, implicating 1207 individuals. Of these individuals, 143
were sentenced to prison for five or more years (with the maximum prison term being
seven years for IP criminal offenses in China), and 582 were sentenced to prison for less
than five years. See Wang, supra note 2.
50
See Schlesinger, supra note 46, at 9–10. The Chinese government has showed an
apparent resolve to promote a shift from non-judicial to judicial enforcement of IPR. Id.
Also, more and more IP holders seem to be willing to protect their IPR in China through
judicial proceedings.
51
See id.
52
See Hon. George Fu, Recent Developments in China’s Judicial Protection of
Intellectual Property Rights, Presentation at the International Intellectual Property Society
(Dec. 18, 2003) (transcript on file with author). The Chinese judicial system consists of
the following courts at four levels: (1) Supreme People’s Court; (2) Higher People’s
Court (each province, autonomous region, or municipality directly under the authority of
the central government, has one Higher People’s Court); (3) Intermediate People’s Court
(each major city has one or two Intermediate People’s Courts); and (4) Basic People’s
Court (each county and each district of major cities has one Basic People’s Court). China
adopts a “two-instance” trial system. In most cases, Intermediate Courts are the first
instance courts for IPR cases. See CCPIT Patent and Trademark Law Office,
Enforcement of Intellectual Property Rights - Judicial System, at http://www.ccpitpatent.com.cn/ip_forms/IP_Enforcement.htm#a1 (last visited Oct. 25, 2004).
53
See Fu, supra note 52, at 2.
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IPR administrative decisions are subject to judicial review by
the People’s Courts.54 For example, a party who is dissatisfied
with an initial ruling in an administrative proceeding on patent
infringement may appeal to Intermediate People’s Courts at the
provincial level or other Intermediate People’s Courts specially
designated by the Supreme People’s Court.55 For cases concerning
whether an IP right should be granted, or whether a granted IP
right should be revoked, however, the Supreme People’s Court has
granted the Beijing Intermediate Courts exclusive jurisdiction.56
Thus, a patent holder dissatisfied with the invalidation of his patent
by the SIPO Patent Reexamination Board will have to appeal the
decision to the Beijing Intermediate Courts.57
II. POST-GRANT PATENT INVALIDATION IN CHINA
In discussing the patent invalidation procedure in SIPO, this
section will address the following aspects in succession: a brief
history of the patent-invalidation system; when, by whom, and on
what grounds can requests for invalidation be filed; the
composition of the Reexamination Board; opportunity for
participation by the parties involved (including oral proceedings);
possible outcomes of the reexamination and their effects; appeal
procedure; and statistics of usage of the invalidation procedure.

54

See id. at 4.
See id. at 2.
56
See id. The Beijing Intermediate Courts’ exclusive jurisdiction also includes matters
involving compulsory licensing. Id.
57
Therefore, although the post-grant patent invalidation procedure at SIPO is used
relatively frequently (see infra Part II.G), it is not that 50% of all the patent-related suits
in Chinese courts are appeals from patent invalidation decisions of the Patent
Reexamination Board. This percentage applies only to the Beijing Intermediate People’s
Courts, but not to all the People’s Courts across China. See supra note 15 and
accompanying text.
55
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A. History of Patent Opposition/Invalidation Provisions in the
Patent Law
Before it was amended in 1992, the Chinese Patent Law
provided for a pre-grant opposition procedure.58 In the 1992
amendment, this pre-grant opposition was abolished and replaced
by post-grant opposition (or revocation).59 This change shortened
the time required to grant a patent by six to ten months, depending
on the type of patent application.60 Thus, before the 2000
amendment, the Patent Law provided for both a post-grant
opposition and a post-grant invalidation procedure.61 The two
procedures serve essentially the same function and there existed an
overlap.62 The differences between the two lay in the time allowed
for filing a claim, the grounds on which the revocation or
invalidation claim can be based, and the authorities that will accept
the claim.63
Experience demonstrated that the post-grant
opposition procedure added to SIPO’s burden of examination.64
Also, the invalidation procedure cannot begin until the opposition
procedure ends, and this could adversely affect a concerned party’s
interest.65 To address these problems, the 2000 amendment of the
Patent Law eliminated the post-grant opposition procedure.66
Consequently, under the current Patent Law, the invalidation
procedure is the single mechanism for challenging a patent’s
validity.67 This approach is considered to be consistent with the
requirements of TRIPS.68
58

See East IP Group, The Latest Amendments to the Chinese Patent Law - A
Comparative Study of the Patent Law with the TRIPS Agreement, at
http://www.eastip.com/news_publications/latestamendment (Oct. 17, 2001).
59
See id. Although the pre-grant opposition procedure is eliminated, one may, from
the date a patent application is published, until the date the patent right is granted, submit
to the SIPO one’s observations that the application is not in conformity with the
provisions of the Patent Law. See Implementing Regulations, supra note 30, Rule 48.
60
See East IP Group, supra note 58.
61
See id.
62
See id.
63
See Zhang, supra note 25.
64
See East IP Group, supra note 58.
65
See Zhang, supra note 25.
66
See East IP Group, supra note 58.
67
See id.
68
See id.
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B. Request for Invalidation and Grounds Therefore
Once a patent is granted, any person (either an individual or an
entity) who believes that the patent should not have been granted
pursuant to the Patent Law, can request that the Patent
Reexamination Board declare the patent invalid.69 There is no
requirement in the Patent Law that the identity of the true party in
interest be disclosed.
The request for invalidation shall state in detail the grounds for
filing the request, by specifying the sections or articles of the
Patent Law or the Implementing Regulations, and provide
evidence for each ground.70 Rule 64(2) of the Implementing
Regulations provides a list of grounds on which an invalidation
request can be based.71 Such grounds include issues relating to,
inter alia, (1) novelty, inventiveness, and practical applicability;72
(2) enablement and written description;73 (3) amendments that go
beyond the scope of the patent application’s original disclosure;74
(4) whether the subject matter is patentable;75 (5) double
patenting;76 and (6) formal matters.77 Thus, the grounds for
invalidation in China are much broader than those available in the

69

See Chinese Patent Law, supra note 27, art. 45.
See Implementing Regulations, supra note 30, Rule 64(1); Guidelines, supra note 42,
pt. IV, ch. 3, § 3.1.
71
Implementing Regulations, supra note 30, Rule 64(2) (“The grounds on which the
request for invalidation is based . . . mean that the invention-creation for which the patent
right is granted does not comply with the provisions of Article 22, Article 23, or of
Article 26, paragraph three or four, or of Article 33 of the Patent Law, or of Rule 2, or of
Rule l3, paragraph one, or of Rule 20, paragraph one, or of Rule 21, paragraph two of
these Implementing Regulations; or the invention-creation falls under the provisions of
Articles 5 or 25 of the Patent Law; or the applicant is not entitled to be granted the patent
right in accordance with the provisions of Article 9 of the Patent Law.”).
72
See Chinese Patent Law, supra note 27, art. 22.
73
See id. art. 26.
74
See id. art. 33.
75
See id. arts. 5, 25; Implementing Regulations, supra note 30, Rule 2.
76
See Implementing Regulations, supra note 30, Rule 13(1).
77
See, e.g., id. Rule 20(1) (“The claims shall define clearly and concisely the matter for
which protection is sought in terms of the technical features of the invention or utility
model.”); cf. 35 U.S.C. § 112, ¶ 2 (2003) (“The specification shall conclude with one or
more claims particularly pointing out and distinctly claiming the subject matter which the
applicant regards as his invention.”).
70
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United States.78 As mentioned supra in Part I.B, under the Patent
Law of China, “[n]ovelty means that, before the date of filing, no
identical invention . . . has been publicly disclosed in publications
in the country or abroad or has been publicly used or made known
to the public by any other means in the country.”79 This is in sharp
contrast with the practice in the United States, where grounds for
questioning the validity of a patent—a substantial new question of
patentability—must be based on patents or printed publications.80
C. The Patent Reexamination Board
The Patent Reexamination Board is composed of a Director, a
Deputy Director, Members, and Examiners for Reexamination.81
The position of Director is held by the Commissioner of SIPO.82
The Deputy Director and the Members are appointed by the
Commissioner from experienced technical and legal experts of
SIPO.83 Examiners for Reexamination are experienced examiners
and legal staff selected from SIPO.84
An invalidation case can be handled by a collegiate panel or by
a sole examiner.85 A collegiate panel consists of three to five
members, including a panel leader, one chief examiner and one or
three associate examiners.86 A five-person panel shall be used, as
determined or approved by the Director of the Board, if the case
(1) has great impact in China and abroad, (2) involves important or
difficult legal issues, or (3) involves great economic interests.87
78

See infra Part III.C.2.a for grounds for requesting patent reexamination in the United
States.
79
See Chinese Patent Law, supra note 27, art. 22(2) (emphasis added).
80
See infra Part III.C; see also infra Part IV, regarding the meaning under the Patent
Law of China of “public disclosure,” which includes disclosure by publication and nonpublication disclosure.
81
See Guidelines, supra note 42, pt. IV, ch. 1, § 4.
82
See id.
83
See id.
84
See id.
85
See id. §§ 6–7.
86
See id. § 6.
87
See id. § 6.2. The Viagra case is clearly a case that involved great economic
interests. Indeed, SIPO had established a special committee to examine the case. See
Pfizer Says China Has Overturned Viagra Patent, ASSOCIATED PRESS,
http://www.forbes.com/business/feeds/ap/2004/07/07/ap1446796.html (July 7, 2004).
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An opinion of a collegiate panel is reached through voting,
wherein the majority opinion controls.88 Simple cases may be
examined independently by a single examiner.89 A member of the
Patent Reexamination Board shall be excluded from the
invalidation proceedings if he is deemed an interested party or was
involved in the original examination of the application from which
the patent issued.90
D. Conduct of the Reexamination
In conducting the reexamination of a patent, the Reexamination
Board shall abide by the principles of legality, fairness, petition,
hearings, and publicity.91 The principle of legality requires that the
reexamination procedure and decision conform to applicable laws
and rules;92 the principle of fairness requires the Board to reach a
decision objectively, correctly, and timely, based on the facts and
the law;93 the principle of petition allows the person who has filed
the request for invalidation to withdraw the case before the Board
has reached a decision;94 the principle of hearings allows the party
to whom a determination is unfavorable an opportunity to provide
observations against the grounds, evidence or affirmed facts
adopted in the decision;95 and the principle of publicity requires
that, except for cases that should be kept confidential according to
law, oral hearings be held publicly and the decision of the
reexamination be published.96
The reexamination is inter partes in nature. The Board will
send a copy of the request for invalidation and relevant

88

See Guidelines, supra note 42, pt. IV, ch. 1, § 6.4.
See id. § 7.
90
See id. § 8; see also Implementing Regulations, supra note 30, Rule 38.
91
See generally Guidelines, supra note 42, pt. IV, ch. 1, § 5.
92
See id. § 5.1.
93
See id. § 5.2.
94
See id. § 5.3. The petitioner who requested the invalidation, however, cannot
withdraw the case after the Board has announced or issued a decision in writing. Such a
decision is binding notwithstanding the attempt by petitioner to withdraw the case. Id.
95
Id. § 5.5.
96
Id. §§ 5.6, 9.3.
89
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documents97 to the patent owner,98 and invite the patent owner to
respond within a specified time limit,99 which is usually within a
month100 and not extendible.101 Depending on the circumstances
of the reexamination, the Board may also transfer to the person
requesting the invalidation any observations filed by the patentee
in response to the request for invalidation, and, when necessary, set
a time limit (usually one month) for response.102 If a party fails to
respond within the time limit, the party will be deemed to have
known the grounds, facts and evidence contained in the transferred
documents and to have raised no opposition.103
The Board may also conduct investigations ex officio on the
case.104 In general, however, the Board will conduct the
reexamination only on the grounds that the requester raises and is
not obliged to perform a comprehensive examination of the
validity of the challenged patent.105
The patentee is permitted to amend the claims of the patent,
provided that such amendment does not broaden the scope of
patent protection.106 The patentee, however, cannot amend the
description or drawings of the patent.107 If the amendment of the
claims is done by means other than deletion, the person requesting

97

Within one month after the filing date of the request for reexamination, the person
making the request may supply additional evidence or arguments. See Implementing
Regulations, supra note 30, Rule 66.
98
Id. The terms “patent owner,” “patentee,” and “the proprietor of the patent” (and
variations thereof) are used interchangeably in this paper, although their legal meanings
are not exactly the same.
99
See Implementing Regulations, supra note 30, Rule 67(1).
100
See Guidelines, supra note 42, pt. IV, ch. 3, § 5.1.
101
See Implementing Regulations, supra note 30, Rule 70 (“In the course of the
examination of a request for invalidation, the time limit specified by the Patent
Reexamination Board shall not be extended.”).
102
See Guidelines, supra note 42, pt. IV, ch. 3, § 5.1; see also Implementing
Regulations, supra note 30, Rule 67(2).
103
Guidelines, supra note 42, pt. IV, ch. 3, § 5.1.
104
Guidelines, supra note 42, pt. IV, ch. 1, § 5.4.
105
See Guidelines, supra note 42, pt. IV, ch. 3, § 3.1.2.
106
See Implementing Regulations, supra note 30, Rule 68(1).
107
See id. Rule 68. The drawings, photographs, or the brief explanation of a design
patent cannot be amended. Id.
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the invalidation is given an opportunity to raise new grounds,
evidence and observations against the amended claims.108
The Board may, at the request of the parties or at its discretion
based on the needs of the case, decide to hold oral hearings during
the reexamination process.109 A party shall submit the request for
oral hearing in writing, setting forth the grounds for such
request.110 As already mentioned, the oral hearings shall be
conducted publicly, subject to situations where confidentiality is
required by law.111 To guarantee fairness, a member of the Panel
usually cannot interview with only one side to the
reexamination.112
E. Outcomes of the Invalidation Proceeding and Their Effects
An invalidation proceeding may take up to two years,113 with
three possible outcomes: (1) the entire patent is declared invalid;
(2) part of the patent is declared invalid; and (3) the patent is
upheld.114 Any patent right (or part thereof) that has been declared
invalid is deemed to have not existed from the beginning.115 The
claims (including amended claims) of a patent that is upheld are
deemed to have existed from the very beginning.116
Importantly, a decision by the Board declaring a patent invalid
will not have retroactive effect on any judgment of patent
108

See Guidelines, supra note 42, pt. IV, ch. 3, § 5.4.
See Implementing Regulations, supra note 30, Rule 69(1). In a case before a fiveperson panel, oral hearings shall be conducted if such hearings have not been conducted
previously in the case before the five-person panel is established. See Guidelines, supra
note 42, pt. IV, ch. 1, § 6.2. By inference, oral hearings—which would have been
public—had probably been conducted in the Viagra case, because it was handled by a
special panel. See supra note 87.
110
The grounds for requesting an oral hearing may include: “(1) one party wishes to
have a face-to-face cross-examination and argument with the adversary; (2) it is
necessary to state the facts before the Panel; (3) it is necessary to make [a] demonstration
in kind; (4) it is necessary to present witnesses to testify.” See Guidelines, supra note 42,
pt. IV, ch. 4, § 2.
111
See Guidelines, supra note 42, pt. IV, ch. 5, § 5.2.
112
See Guidelines, supra note 42, pt. IV, ch. 3, § 3.6.
113
See East IP Group, supra note 58.
114
Guidelines, supra note 42, pt. IV, ch. 3, § 6.
115
See Chinese Patent Law, supra note 27, art. 47(1); Guidelines, supra note 42, pt. IV,
ch. 3, § 6.
116
See Guidelines, supra note 42, pt. IV, ch. 3, § 6.
109
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infringement that has been pronounced and enforced by the
People’s Court, or on contracts relating to licensing or assignment
of patent rights that have been performed before the declaration of
the patent’s invalidity.117 But the patent owner will be liable for
damages caused to other parties due to its bad faith.118 Also, the
original owner of the now invalid patent should repay a licensee or
an assignee the whole or part of the patent licensing or assignment
fees if not doing so would be contrary to the principle of equity.119
Because post-grant patent invalidation proceedings must be
initiated at the SIPO Patent Reexamination Board,120 and because
the Beijing People’s Intermediate Courts are the designated courts
for appeal of the Board’s decision, a situation can arise where a
patent is affirmed to be invalid in the Beijing Intermediate Courts,
but the same patent is found infringed in another People’s Court
elsewhere in China.121 Thus, when an invalidation request has
been filed in the SIPO, it is a critical issue whether to stay an
infringement proceeding in a court other than the Beijing
Intermediate Courts.122 A Supreme Court circular issued before
the 2000 amendment of the Patent Law suggested that the courts
have the discretion (but not the obligation) to order a stay if
invalidation proceedings are pending in the SIPO.123
In
infringement cases involving utility models and designs, such a
stay is almost automatic. In invention patent cases, however, stays
are not as common.124 One explanation for this differential
treatment is that, because invention patents, unlike utility model or
design patents, are only granted after substantive examination, the
People’s Court can proceed with the infringement hearing

117

See Chinese Patent Law, supra note 27, art. 47(2).
See id.
119
See id., art. 47(3).
120
Pursuant to Articles 41, 45 and 46 of the Patent Law, the Patent Reexamination
Board performs examinations of requests for invalidation of granted patents (as well as
requests for reexamination of the Patent Office’s decision on examination of patent
applications). See Guidelines, supra note 42, pt. IV, ch. 1, § 3.
121
See East IP Group, supra note 58.
122
See id.
123
See id.
124
See id.; see also John Richards, Guide to Patent Protection in the Pacific Rim 20
(Spring 2004) (unpublished manuscript, on file with author).
118
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involving an invention patent with the presumption that the
invention patent is valid.125
On the other hand, the Reexamination Board should
temporarily suspend the invalidation proceedings if the People’s
Court has ordered a patent right preservation concerning the
challenged patent and has requested the Board to assist exercising
the preservation of the patent right.126 Temporary suspension of
the invalidation proceedings will also be effected when there is a
dispute over the ownership of the patent right and a party involved
in the dispute requests suspension of the invalidation
The Board can resume the invalidation
proceedings.127
proceedings if, inter alia, (1) the party that requested suspension
now requests restoration of the proceedings; (2) no request to
extend the suspension has been received after one year of
suspension based on a patent right ownership dispute; or (3) the
People’s Court has issued no order to continue the preservation of
patent right after the expiration of the time limit for
preservation.128
F. Appeal
Before the 2000 amendment, a decision by the Board regarding
the validity of a utility model or design patent was final, while a
decision by the Board on the validity of an invention patent was
subject to appeal.129 To comply with TRIPS, which requires that
administrative decisions in any proceeding for the acquisition and
maintenance of intellectual property rights be subject to judicial
review,130 the 2000 amendment removed the finality of the Board’s
decision on the validity of the patent right for utility models and
designs.131
125

See East IP Group, supra note 58.
See Implementing Regulations, supra note 30, Rule 87; Guidelines, supra note 42,
pt. IV, ch. 3, § 5.5.
127
See Implementing Regulations, supra note 30, Rule 86; Guidelines, supra note 42,
pt. IV, ch. 3, § 5.5.
128
See Implementing Regulations, supra note 30, Rule 86–87; Guidelines, supra note
42, pt. IV, ch. 3, § 5.5.
129
See East IP Group, supra note 58.
130
See TRIPS Guidelines, supra note 12, art. 62, ¶ 5.
131
See East IP Group, supra note 58.
126
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Under the current Patent Law, any party not satisfied with the
decision of the Board may, within three months from receipt of the
notification of the decision, appeal to the People’s Court.132 As
mentioned earlier, the appeal will be taken up at the Beijing
Intermediate People’s Courts.133 The SIPO Patent Reexamination
Board is the defendant in the appeal.134 The Court will notify the
party who opposed the now appellant in the invalidation
proceedings to appear as a third party.135 A party dissatisfied with
the Intermediate Court’s decision can further appeal to the Beijing
Higher People’s Court.136
If the decision of the Reexamination Board has been
withdrawn by a valid People’s Court judgment but the court does
not enter its own ruling on the validity of the patent, the Board will
need to re-conduct the invalidation proceedings.137 If the Board’s
original decision has been withdrawn by the court for insufficient
evidence or erroneous application of law during the invalidation
proceedings, the Board cannot, in reexamining the invalidation
case, reach the same decision based on the same evidence or
reasoning.138 If the original Board decision has been withdrawn
for procedural errors, the Board shall re-examine the invalidation
case based on the correct procedures as determined by the People’s
Court.139
G. Statistics on the Use of the Invalidation System
According to the 2002 Annual Report of SIPO, “[s]ince 1985,
the Patent Re-examination Board [has] received 8594 requests for

132

See Chinese Patent Law, supra note 27, art. 46(2).
See supra note 52 and accompanying text.
134
See Guidelines, supra note 42, pt. IV, ch. 3, § 5.6.
135
See Chinese Patent Law, supra note 27, art. 46(2). Thus, in the Viagra case, the
appeal will be Pfizer v. SIPO Patent Reexamination Board, with the Chinese companies
that requested the invalidation participating as third parties.
136
For an illustration of the appeal procedures, see Chinese Patent Agent (H.K.) Ltd.,
Buhler A.G. v. Patent Reexamination Board, at http://www.cpahkltd.com/publications/cases/ebuhle.html (last visited Oct. 25, 2004) (brief description of case).
137
See Guidelines, supra note 42, pt. IV, ch. 1, § 13.1.2.
138
See id. § 13.2.
139
See id. § 13.3.
133
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invalidation.140 In 2002, 1752 requests for invalidation were
received, 436 more than in the previous year, representing an
increase of 33.1%.141 Of [the] requests received in 2002, 130
related to invalidation requests for invention patents, accounting
for 7.4% of the total, 756 related to invalidation requests for utility
models, accounting for 43.2%, and 866 to industrial designs,
making up the remaining 49.4%.”142 In 2002, about 132,500
patents were granted in China, with about 21,500 for inventions,
57,500 for utility models, and 53,500 for industrial designs.143
Thus the number of requests for invalidation in 2002 represents
just over 1.3% of the number of patents granted in 2002.144
According to the 2002 Annual Report, since 1985, 352 cases
have been lodged with the Beijing Number One Intermediate
People’s Court due to dissatisfaction with invalidation decisions
made by the Patent Reexamination Board.145 In 2002 alone, 211
appeals were brought to the Beijing Number One Intermediate
People’s Court (or to the Beijing High People’s Court), of which
twenty-five were against the invalidation decisions involving
invention patents, 116 involving utility model patents, and seventy
involving industrial designs.146 Evidently, the total number of
appeals increased dramatically in 2002, exceeding the total number
of appeals from 1985 to 2001. This is clearly the result of the 2000
amendment to the Patent Law—effective July 1, 2001—that allows
140
State Intell. Prop. Office of the P.R.C., ANN. REP. 2002, Chapter V: Reexamination
and Invalidation, at http://www.sipo.gov.cn/sipo_English/ndbg/nb/ndbg2002/default.htm
(last visited Oct. 25, 2004) [hereinafter Annual Report 2002].
141
Id. This increase may not necessarily mean that the post-grant invalidation process is
gaining popularity. Rather, it is likely the result of the rapidly growing number of patent
applications and grants in China. See generally Intell. Prop. L. Bull., Boom for Patent
Application in China (Mar. 25, 2004), at http://www.iplawbulletin.com/cgibin/absolutenm/anmviewer.asp?a=1180; Annual Report 2002, supra note 140, at ch. II,
§ 4 (“Chapter II: Patent Application and Examination”).
142
Annual Report 2002, supra note 140, ch. V.
143
Annual Report 2002, supra note 140, ch. II, § 4.
144
The real percentage of patents subject to invalidation requests is likely higher than
1.3%, because many of the requests in 2002 are against patents issued before 2002; the
percentage is also likely growing because now requesters of invalidation of utility model
and design patents can appeal an unsatisfactory decision by the Reexamination Board
(see supra note 131 and accompanying text).
145
Annual Report 2002, supra note 140, ch. V.
146
Annual Report 2002, supra note 140, ch. V.
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for appeals of the Board’s invalidation decisions involving utility
model and design patents,147 which constitute the vast majority of
the invalidation proceedings.148
III. POST-GRANT PATENT INVALIDATION IN THE TRILATERAL
OFFICES
This section examines the systems for challenging the validity
of granted patents in the trilateral patent offices of Japan, the EPO,
and the United States. The major aspects of each of these
invalidation systems are discussed in largely the same sequence as
for the Chinese system.
A. Japan
1. Brief History of the Japanese Patent Invalidation System
The Japanese law on challenging a granted patent in the Japan
Patent Office (JPO) has been recently revised. Before 1996, an
interested party could challenge the grant of a patent or a granted
patent through pre-grant opposition or a patent invalidity trial.149
Because the pre-grant opposition procedure caused delays in the
issuance of patents and resulted in undue harassment of the
applicant, it was terminated in 1996 and replaced with post-grant
opposition.150 All the opposition or invalidation proceedings were
to be conducted within the JPO, which had exclusive (firstinstance) jurisdiction over all issues relating to the validity of a
Japanese patent.151 While this is still largely true, in April 2000,
the Supreme Court of Japan in Texas Instruments, Inc. v. Fujitsu
147

See supra note 131 and accompanying text.
See supra note 142 and accompanying text.
149
See generally Setsuko Asami, The New Patent Office Trial of Invalidity:
Administrative Patent Trials under the 2003 Amendments to the Japanese Patent Law, at
2–4, paper presented at the Eleventh Annual Conference on International Intellectual
Property Law & Policy, Fordham University School of Law, Apr. 24 & 25, 2003, New
York City.
150
See, e.g., Gerald J. Mossinghoff and Vivian S. Kuo, Post-Grant Review of Patents:
Enhancing the Quality of the Fuel of Interest, 85 J. PAT. & TRADEMARK OFF. SOC’Y 231,
247; Asami, supra note 149, at 2–3.
151
See Mossinghoff and Kuo, supra note 150, at 247.
148
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Ltd.152 held that “[even] before the decision invalidating a patent
has become final [at the JPO], where a court determines that there
has been infringement of a patent, it should determine whether any
reason for invalidity exists,” and that a patent is invalid if there are
obvious reasons for invalidity and if there is a high level of
certainty that the JPO would invalidate the patent at an invalidation
trial.153
Post-grant opposition, introduced partly as a result of
discussions between the United States Patent and Trademark
Office (USPTO) and the JPO,154 had its own problems. A postgrant opposition is not inter partes, but ex parte, precluding the
party who challenges the validity of the patent from
participation.155 The true party in interest must be identified in the
opposition156 and the opposition must be filed within six months of
the patent’s issue date.157 Due to the ex parte nature of the post152

This case is also known as the “Kilby case.” An English translation of the case is
available at http://www.softic.or.jp/en/cases/Texas_Inst_v_Fujitsu.html (last visited Oct.
25, 2004).
153
See Judge Shuhei Shiotsuki, Invalidation Procedure and Infringement Trials in
Japanese Courts and Patent Office, in 7 CASRIP PUBLICATION SERIES, RECONCILING
INTERNATIONAL INTELLECTUAL PROPERTY 87, 88–89, http://www.law.washington.edu/casrip/Symposium/Number7/2B-Shiotsuki.pdf (July 2002); see also Ladas & Parry LLP,
Japan – Consideration of Validity of Patent in Infringement Action, at
http://www.ladas.com/BULLETINS/2002/0202Bulletin/JapanValidityInInfrigement.html
(Feb. 2002) (“In Japan the law provides that matters relating to the validity of patents
should be dealt with by nullity proceedings initiated before the Patent Office. Invalidity
of the patent being sued upon is not in itself a defense to an infringement lawsuit in
Japan, although on occasion, courts have construed patents narrowly in cases where they
have felt the patent unlikely to be valid. As a practical matter, this situation may be about
to change. In April 2000 in Texas Instruments v. Fujitsu Ltd. the Japanese Supreme
Court held that, in cases where a court hearing an infringement action concluded that it
was highly likely that the patent was invalid, it could decline to enforce it, since any such
enforcement would be a misuse of the patent right. It therefore appears that defendants
will now have a clear interest in raising issues of invalidity when sued for patent
infringement. The case in which the issue arose was one where the ground of invalidity
in question was the Japanese equivalent of double patenting and was fairly easy for the
court to understand. Whether courts will be willing to consider issues of obviousness or
other more complex allegations of invalidity in infringement trials remains to be seen. In
such cases it may still be necessary to use the traditional route of a nullity suit.”).
154
See Asami, supra note 149, at 2–3.
155
See id. at 3.
156
See id. n.3.
157
See id. at 3.

SUN

298

1/25/2005 6:16 PM

FORDHAM INTELL. PROP. MEDIA & ENT. L.J.

[Vol. 15:273

grant opposition procedure, the party challenging the patent lost
about 80% of all oppositions.158 Furthermore, the party losing the
opposition to the patentee has no right of appeal to the Tokyo High
Court.159 Consequently, the total number of oppositions declined
from 6000 in 1998 to about 3500 in 2001, representing
approximately three percent of all granted patents.160 The number
of invalidation trials, however, has remained constant, at just
below 0.3% of all granted patents.161
Because of the dual opposition and invalidation trial system,
patentees are burdened by repeated attacks against the same patent
and a resolution of patent validity is delayed.162 In 2003, seven
years after its introduction, the post-grant opposition procedure
was abolished,163 leaving a modified invalidation trial system as
the sole mechanism for nullifying a Japanese patent filed or issued
after January 1, 2004.164 The new “Trial for Invalidity,” effective
January 1, 2004, is largely an integration of the two previous
procedures of post-grant opposition and invalidation trial.165
2. Initiation and Conduct of the Trial for Invalidity
Under the new Trial for Invalidity system, the request for
invalidation trial can be filed at any time,166 even after the
expiration of the patent term.167 The identity of the true party in
158

See id.
See id.
160
See id.
161
See id. The success rate for the challenging party in invalidation trials is about 24%,
slightly higher than in oppositions, but it has been increasing. See id.
162
See id.
163
See id. at 1–2.
164
See id. The post-grant opposition system will continue to be available for any patent
granted on or before December 31, 2003. See Harold C. Wegner, Tokyo Patent
Enforcement & Invalidation: Implications for American Litigation from Blonder-Tongue
to Trans-Border Enforcement, 8 n.12, paper presented at the Eleventh Annual Conference
on International Intellectual Property Law & Policy, Fordham University School of Law,
April 24 & 25, 2003, New York City.
165
See, e.g., Masaki Yoshino, Patent Law Amended, Practical Law Company, at
http://www.plcinfo.com/scripts/article.asp?Article_ID=35697 (last visited Oct. 25, 2004).
166
See Asami, supra note 149, at 3.
167
See Japan Patent Law, § 123(2) (1999), an English translation of which is available
at http://www.jpo.go.jp/shoukaie/patent.htm (last visited Oct. 18, 2004) [hereinafter
Japan Patent Law].
159
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interest need not be identified.168 The entire procedure is inter
partes.169 The patentee can file a response to the invalidation
request, and the response can include narrowing amendments to
the claims.170 The requester generally will have a second
opportunity to furnish new evidence, usually in response to
narrowing amendments by the patentee.171 The trial will proceed,
generally in the format of an oral hearing,172 before a threemember panel of the Board of Appeals and Trials,173 which
reaches a final decision in about fifteen months.174 The members
of the JPO Board of Appeals and Trials are highly experienced.
Each member has at least ten years of patent examination
experience, as well as excellent educational backgrounds.175
3. Grounds for Invalidation
Under the new invalidation trial system, challenges to patent
validity can be based on almost any ground upon which a patent
may be found invalid.176 As many as sixteen specific grounds have
been articulated by some practitioners.177 Interestingly, however, a
168

See Asami, supra note 149, at 2, 4. The procedure before January 1, 2004 requires
that only an interested party may seek a Trial for Invalidity. See Wegner, supra note 164,
at 9 n.13.
169
See Wegner, supra note 164, at 8 n.12.
170
See Asami, supra note 149, at 5.
171
See id.
172
See id.; Wegner, supra note 164, at 9.
173
The Board of Appeals and Trials, with more than 300 members, handles not only
Trials for Invalidity and oppositions, but also appeals from rejections of patent
applications. In 2001, there were about 300 Trial for Invalidity cases, 3500 oppositions,
and 20,000 appeals of patent application rejections. See Asami, supra note 149, 2 n.2 and
accompanying text.
174
See id. at 6.
175
Most members are graduates of Japan’s top universities and more than 85% have a
Master’s degree. See id. at 5; Wegner, supra note 164, 9 n.15. The qualifications of the
panel members of the Patent Examination Board of the SIPO are similar to those of the
JPO. See supra Part II.
176
See Japan Patent Law, supra note 167, § 123(1).
177
See Global IP Group, Japanese Patent Law, IX: Trial for Invalidity, at
http://www.shinjyu.com/articles/01Japanese_Patent (last visited Oct. 18, 2004), which
provides:
A third party who is or may be adversely affected by a patent may demand a
trial for the invalidation of the patent under the following circumstances:
(1) new matter was added to the application during prosecution;
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patent cannot be invalidated on the ground that the applicant
intentionally withheld relevant prior art during prosecution, even if
such prior art could conceivably render the invention
unpatentable.178
4. Outcomes of the Invalidation Trial and Their Effects
The decision of the invalidation trial can be to revoke the
challenged patent, to maintain the patent as granted, or to maintain
the patent as amended.179 A patent right will be deemed never to

(2) a patent was granted to an applicant that is a resident of a country which
does not grant reciprocal privileges to Japanese residents;
(3) the invention is not industrially applicable;
(4) the invention was publicly known in Japan prior to the filing date of the
application;
(5) the invention was publicly worked in Japan prior to the filing date of the
application;
(6) the invention was described in a publication distributed in Japan or
elsewhere prior to the filing date of the patent application;
(7) the invention could have been easily made, prior to the filing date of the
application, by a person with ordinary skill in the art to which the invention
pertains;
(8) the applicant was not the first one to file a patent application for the
invention;
(9) the invention is liable to contravene public order, morality or public health;
(10) the patent was granted contrary to the provisions of a treaty;
(11) the specification does not describe the invention in a manner sufficiently
clear and complete for the invention to be carried out by a person having
ordinary skill in the art to which the invention pertains;
(12) the allowed claims are not clear and concise;
(13) an English language patent application was originally filed, and the
Japanese language translation of such includes matter not disclosed in the
English version.
(14) the patent has been granted on a patent application filed by a person who is
not the inventor and has not succeeded to the right to obtain a patent for the
invention concerned;
(15) when the patentee has become a resident of a country that does not grant
reciprocal privileges to residents of Japan, or the patent in question no longer
complies with a treaty; and
(16) the patentee has been allowed to correct the specification or drawings of
the patent after grant in a manner which adds new matter.
178
See id. (XIV: Prior Art Disclosure Requirement).
179
See Mossinghoff & Kuo, supra note 150, at 248; see also supra note 170 and
accompanying text.
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have existed if a final and conclusive decision has been made that a
patent is invalid.180
5. Appeal
Either the requester or the patentee may seek review in the
Tokyo High Court.181 The patentee seeking such an appeal has a
further opportunity to make narrowing amendments to the
patent.182
Under the new Trial for Invalidity rules, such
amendments must be made within ninety days of the Trial Board’s
decision at the JPO.183 The Tokyo High Court can remand the case
back to the JPO when the patentee makes such amendments, and
the JPO will examine both the legitimacy of the patentee’s
requested amendments and the arguments filed by the requester of
the invalidation trial in response thereto.184 In a suit against an
invalidation trial decision, the JPO is not a party to the suit.185
When appropriate, however, the court can request the JPO to state
an opinion relating to the interpretation of the law and examination
guidelines.186 Also, with the court’s permission, the JPO may file
such an opinion on its own initiative.187 A party not satisfied with

180

See Japan Patent Law, supra note 167, § 125.
See Asami, supra note 149, at 6. There are five kinds of courts in Japan: The
Supreme Court, High Courts, District Courts, Family Courts and Summary Courts. It is
likely a result of American influence that the power granted to the Supreme Court and
limitations thereto are somewhat similar to that of the U.S. Supreme Court. Each of the
eight High Courts covers its own territorial jurisdiction, like the U.S. Federal Circuit
courts, but they have original jurisdictions in certain subject matters such as election
disputes. The District Courts have original jurisdiction over all cases except those that
fall within the specific jurisdiction of other courts. The Family Courts, also directly
below the High Courts (like the District Courts, to which they are parallel), hear both
cases involving family conflicts, as well as juvenile delinquency cases. The Summary
Courts, which are directly under the District Courts, hears small claims civil cases and
certain minor criminal cases. See Supreme Court of Japan, An Overview of the Judicial
System, at http://www.courts.go.jp/english/soshikie_1.html (last visited Oct. 26, 2004).
182
See Asami, supra note 149, at 6.
183
See id.
184
See id. at 6–7.
185
See Onda Techno, Amendments to Japanese Patent Law, Statement of Opinion by the
JPO in a Suit against Trial Decision, at http://www.ondatechno.com/English/topics/20040205.html (last visited Oct. 26, 2004).
186
See id.
187
See id.
181
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the decision of the Tokyo High Court may appeal to the Supreme
Court.188
6. Statistics of Use
In 2001, about 110,000 patents were granted in Japan.189
Against the granted patents, about 4000 oppositions and 283
invalidation trials were demanded,190 representing about 4% of the
granted patents. Of the Board’s decisions in the invalidation trials
in the same year, 156 were appealed to the Tokyo High Court.191
In contrast, only 153 infringement suits were filed in District
Courts in Japan in 2001,192 a very small number compared to the
more than 1700 cases filed in the United States in the same year.193
It is too early to see how frequently Japan’s new invalidation trial
system will be used.
B. EPO
The European Patent Convention (“EPC”) went into effect on
June 1, 1978 with the opening of the European Patent Office
(EPO) in Munich.194 The EPC provides for an opposition
procedure for challenging a granted European patent.195

188

See Shiotsuki, supra note 153, at 87.
See Japan Patent Attorneys Association, 2003 Amendment to Japan Patent Law,
§ 2.1: Recent Statistics in Legal Dispute over a Patent Right, at http://www.jpaa.or.jp/english/law/2003amendment.html (last visited Oct. 26, 2004).
190
See id.
191
See id.
192
See id.
193
See Law.com, Methodology (May 7, 2002), at http://www.law.com/jsp/statearchive.jsp?type=Article&oldid=ZZZKAS5FS0D (citing a survey conducted by IP
Worldwide).
194
European Patent Office, European Patent Convention, http://www.european-patentoffice.org/legal/epc/e/ma1.html#CVN (last amended Dec. 10, 1998) [hereinafter EPC].
In principle, the EPC has nothing to do with the European Community (EC) or European
Union (EU), because it was created by a treaty between the participating countries
(Contracting States), rather than by the EC/EU authorities. See John Richards, Guide to
Patent Protection under the European Patent Convention, 2–5 (unpublished manuscript
on file with author) [hereinafter Richards, Patent Protection under the EPC]. Thus an
EU member is not necessarily an EPC member, and vice versa. For a list of the current
EPC Contracting States, see EPC, art. 1 n.1.
195
See EPC, supra note 194, arts. 99–105.
189
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1. Filing of an Opposition
Through an EPC opposition, any person may obtain the
limitation or revocation of a wrongly granted European patent.196
“Any person” means any natural person (such as private
individuals, self-employed persons, etc.) or any legal person (such
as corporations).197 But “any person” does not include the
proprietor of the patent.198 The person filing an opposition need
not specify any particular interest.199
The notice of opposition has to be filed with the EPO within
nine months from the publication of the grant of the patent.200 An
opposition may be filed even if the European patent has been
surrendered or has lapsed for all the designated States.201 This is to
cover situations where patent right disputes arise from the period
before the surrender or lapse of the patent.202 Also, even if the
period for filing an opposition has expired, a third party may
intervene in the opposition proceedings if he proves that
proceedings for infringement of the patent being opposed have
been instituted against him, or that he has instituted proceedings
for a court ruling that he is not infringing the opposed patent in
response to the patent owner’s request that he cease the alleged
infringement.203 If the notice of intervention is properly filed
within specified time limits (e.g., within three months of the date

196

See European Patent Office, Guidelines for Examination in the EPO, pt. D, ch. I, § 1,
available at http://www.european-patent-office.org/legal/gui_lines/index.htm (2003)
[hereinafter EPO Opposition Guidelines]. There are two ways to obtain patent protection
in Europe, either nationally through patent offices of the individual European countries or
centrally through the EPO in the form of a European patent. The EPC, however, does not
provide a common regime for the enforcement of European patents. See Richards, Patent
Protection under the EPC, supra note 194, at 2–5.
197
See EPC, supra note 194, arts. 58, 99(1).
198
EPO Opposition Guidelines, supra note 196, pt. D, ch. I, § 4.
199
See id.
200
See EPC, supra note 194, art. 99(1). The notice of opposition can be given to the
EPO office in Munich, The Hague or Berlin. See EPO Opposition Guidelines, supra note
196, pt. D, ch. III, § 1.
201
See EPC, supra note 194, art. 99(3).
202
See EPO Opposition Guidelines, supra note 196, pt. D, ch. III, § 2.
203
EPC, supra note 194, art. 105(1).
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on which the infringement proceedings were instituted), the
intervention will be treated as an opposition.204
2. Grounds for Opposition
The notice of opposition shall contain, inter alia, “a statement
of the extent to which the European patent is opposed and of the
grounds on which the opposition is based as well as an indication
of the facts, evidence and arguments presented in support of these
grounds.”205 EPC Article 100 sets forth three categories of grounds
on which the public may oppose a granted European patent:206 (1)
lack of patentability;207 (2) insufficient disclosure;208 and (3)
extension of the scope of protection beyond what was contained in
the application as originally filed.209 For (1) lack of patentability,
the grounds can be that the claimed invention lacks novelty,210
inventive step,211 or industrial application,212 or that the claimed
invention relates to non-patentable subject matter213 or the
exploitation of which is contrary to public interest or morality.214

204

See id. arts. 105(1), 105(2).
Implementing Regulations to the Convention on the Grant of European Patents, Rule
55(c)—Content of the Notice of Opposition, available at http://www.european-patentoffice.org/legal/epc/e/ma2.html#REG (last amended Dec. 13, 2001) [hereinafter EPC
Regulations].
206
EPC, supra note 194, art. 100.
207
Id. art. 100(a) (“[T]he subject-matter of the European patent is not patentable within
the terms of Articles 52 to 57.”).
208
Id. art. 100(b) (“[T]he European patent does not disclose the invention in a manner
sufficiently clear and complete for it to be carried out by a person skilled in the art.”).
209
Id. art. 100(c) (“[T]he subject-matter of the European patent extends beyond the
content of the application as filed, or, if the patent was granted on a divisional application
or on a new application filed in accordance with Article 61, beyond the content of the
earlier application as filed.”).
210
Id. art. 54.
211
Id. art. 56.
212
Id. art. 57.
213
See id. arts. 52, 53(b).
214
See id. art. 53(a). But the publication or exploitation of the invention “shall not be
deemed to be so contrary merely because it is prohibited by law or regulation in some or
all of the Contracting States.” Id. This is different from China, which still holds that
inventions that violate Chinese laws are not patentable. See supra note 36 and
accompanying text.
205
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3. The Opposition Division
An Opposition Division is responsible for the examination of
oppositions against any European patent.215 Regarding the
composition, tasks and powers of an Opposition Division, the EPC
provides:
An Opposition Division shall consist of three technical
examiners, at least two of whom shall not have taken part
in the proceedings for grant of the patent to which the
opposition relates. An examiner who has taken part in the
proceedings for the grant of the European patent shall not
be the Chairman. Prior to the taking of a final decision on
the opposition, the Opposition Division may entrust the
examination of the opposition to one of its members. Oral
proceedings shall be before the Opposition Division itself.
If the Opposition Division considers that the nature of the
decision so requires, it shall be enlarged by the addition of
a legally qualified examiner who shall not have taken part
in the proceedings for grant of the patent. In the event of
parity of votes, the vote of the Chairman of the Division
shall be decisive.216
If the notice of opposition is deemed admissible after
evaluation of the formalities,217 “[t]he Opposition Division shall
communicate the opposition to the proprietor of the patent and
shall invite him to file observations and, where appropriate,
amendments to the description, claims and drawings within a
period to be fixed by the Opposition Division.”218
The
observations and any amendments filed by the proprietor are then
communicated by the Opposition Division to all opponents, who,
when deemed necessary by the Opposition Division, are given an
opportunity to comment on the proprietor’s submissions.219

215

EPC, supra note 194, art. 19(1).
Id. art. 19(2). The Chairman must be a technically qualified examiner. See EPO
Opposition Guidelines, supra note 196, pt. D, ch. II, § 2.3.
217
See EPC Regulations, supra note 205, Rule 56 (“Rejection of the notice of
opposition as inadmissible”).
218
Id. Rule 57(1).
219
Id. Rule 57(3).
216
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4. Conduct of the Opposition
The proceeding of the substantive examination before the
Opposition Division is quite flexible. There is no fixed schedule of
pleadings and counter-pleadings between the parties, and the time
limits set by the Opposition Division can be extended for cause.220
Parties are invited by the Opposition Division as often as necessary
to file observations on communications from the other party or
from the Opposition Division.221
Although substantive
examination of the opposition generally starts with written
submissions and evidence, oral proceedings will be held if the
Opposition Division deems it appropriate, or if any party so
requests.222 During the oral proceedings, the parties are not
allowed to introduce new facts or evidence, unless the Opposition
Division concludes that such facts or evidence is critically
important.223 The oral proceedings are public.224
5. Outcomes of the Opposition Proceeding and Their Effects
There are three possible outcomes of an opposition proceeding
in the EPO: (1) revocation of the European patent;225 (2) rejection
of the opposition;226 and (3) maintenance of the European patent as
amended.227 If a European patent has been revoked, the European
patent application and the resulting patent will be deemed to have
not had any rights that would have been conferred by a European
patent application after publication or by a European patent.228
The outcome of the opposition proceedings is published in the

220

See M. Trinidad Arriola, Key Features of the European Patent Office (EPO)
Opposition Procedures, CASRIP NEWSLETTER (Center for Advanced Study and Res. on
Intell. Prop, Seattle, WA.), Spring/Summer 1997, at http://www.law.washington.edu/casrip/newsletter/newsv4i2eu1.html. See also EPC, supra note 194, art. 101(2).
221
See Arriola, supra note 220.
222
EPC, supra note 194, art. 116(1).
223
See Arriola, supra note 220.
224
See EPC, supra note 194, art. 116(4).
225
See id. art. 102(1).
226
See id. art. 102(2).
227
See id. art. 102(3).
228
See id. art. 68.
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European Patent Bulletin as soon as the proceedings are
concluded.229
Even though an opposition is filed with respect to only one or
some of the EPC Contracting States in which that patent has effect
(“the designated States”),230 the opposition applies to the European
patent in all the designated States.231 However, the specific effects
of an opposition may differ among the designated States, because
the patent may contain different claims or different prior art may
exist in different designated States.232 Thus the patent may be
amended differently in different designated States, or may be
revoked in one or more designated States but not in others.233
6. Appeal
Any party to the opposition who is adversely affected by the
decision of the opposition may appeal.234 The other parties to the
opposition have the right to be parties to the appeal proceedings.235
An appeal can be filed even if the European patent has been
surrendered, or has lapsed for all the designated States.236 But the
notice of appeal must be filed in writing within two months of the
notification of the Opposition Division’s decision, and the grounds
for appeal must be filed in writing within four months of the
notification of such decision.237
The appeal is examined by the Board of Appeal.238 During the
examination process, the Board of Appeal, as often as necessary,
invites the parties to file observations on communications from
another party or from the Board of Appeal itself.239 The Board of
229

See EPO Opposition Guidelines, supra note 196, pt. D, ch. I, § 8.
Currently there are the twenty-eight Contracting States in the EPC. See EPC, supra
note 194, art. 1. An applicant for a European patent should designate in which of the
Contracting States protection for the invention is desired. See id. art. 79(1).
231
See id. art. 99(2).
232
See EPO Opposition Guidelines, supra note 196, pt. D, ch. I, § 3.
233
Id.
234
See EPC, supra note 194, art. 107.
235
Id.
236
See id. art. 106(2).
237
See id. art. 108.
238
See id. art. 110(1).
239
See id. art. 110(2).
230
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Appeal can either make a decision on the appeal, or remand the
case back to the Opposition Division for further examination based
on the Board of Appeal’s legal instructions.240 When important
issues of law are involved, or in order to ensure uniform
application of law, the Board of Appeal can refer questions of law
to the Enlarged Board of Appeal.241 The entire opposition
procedure, including appeals, may take up to five years or more.242
7. Statistics of Use
The drafters of the EPC opposition procedure generally
expected, based on prior experience with oppositions at national
patent offices, that about 20–25% of the European patents granted
would be opposed.243 Contrary to these forecasts, however, recent
studies show that oppositions have been filed against just 6–8% of
European patents.244 Data from recent years show that about 35%
of the patents opposed are revoked, about 30% are maintained in
an amended form, and about 35% of the oppositions are
rejected.245
C. United States
1. Brief History of the Reexamination System
Currently, in the United States, a party can challenge the
validity of a U.S. patent in a District Court if the party has been

240

See id. art. 111.
See id. art. 112(1)(a). “For giving decisions or opinions, the Enlarged Board of
Appeal shall consist of five legally qualified members and two technically qualified
members. One of the legally qualified members shall be the Chairman.” Id. art. 22(2).
242
See Arriola, supra note 220.
243
See id.
244
See id. (“At first blush, the number of oppositions filed may seem surprisingly low
when compared to the 25% posted by the German Patent Office in earlier years.
Although this result may be attributed to disfavor for or dissatisfaction with the
opposition procedure, other factors may account for this low turnout. First, trivial and
insignificant applications are usually not filed at the EPO but usually remain with the
national offices; and second, the EPO boasts a superior search procedure compared to
those of the national offices.”).
245
See id.
241

SUN

1/25/2005 6:16 PM

2004]

POST-GRANT PATENT INVALIDATION

309

sued for infringement, or in the USPTO through reexamination
procedures.246
Patent reexamination, i.e., a second examination of an issued
patent, was established in 1980 by Congress,247 which was
concerned with the quality of patents and was trying to restore
confidence in the patent system.248 Congress also had other
considerations in creating this administrative process of
reexamination: to provide a cheaper and quicker way to resolve a
patent validity dispute than through District Courts,249 and to rely
on the expertise of the USPTO in evaluating whether a patent
We now look at the U.S.
should have been granted.250
reexamination systems in more detail and see whether the
objectives of Congress have been achieved.
2. Ex Parte Reexamination
As introduced, the reexamination procedure is ex parte in
nature.251 Under the U.S. patent law, “[a]ny person at any time
may cite to the [Patent] Office in writing prior art consisting of
patents or printed publications which that person believes to have a
bearing on the patentability of any claim of a particular patent.”252
There is no requirement that the person submitting such prior art
request a reexamination.253 If the person explains in writing the
pertinence and manner of applying the prior art to at least one
claim of the patent, the prior art and the explanation become part
of the official file of the patent.254 The identity of the person
submitting the prior art and the explanation can be kept
confidential at such person’s request.255
246

See 35 U.S.C. §§ 282, 302 (2003).
Id. §§ 302–307.
248
See John Whealan, Validity Challenges in Re-examination Proceedings, 7 CASRIP
PUBLICATION SERIES, RECONCILING INTERNATIONAL INTELLECTUAL PROPERTY 42,
http://www.law.washington.edu/casrip/Symposium/Number7/2A-Whealan.pdf
(July
2002). The Federal Circuit was established in the same year. Id.
249
Id.
250
Id.
251
35 U.S.C. §§ 302, 307.
252
Id. § 301.
253
See Whealan, supra note 248, at 42–43.
254
35 U.S.C. § 301.
255
Id.
247
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Any person, including the patent owner, at any time, may file
in writing a request for (ex parte) reexamination of any claim of a
patent on the basis of any prior art cited as described in the last
paragraph.256 The request must set forth the pertinence and
manner of applying the cited prior art to every claim for which
reexamination is requested.257
The Patent Office, within three months after the filing of a
request for reexamination, will determine whether the request
raises a substantial new question of patentability affecting any
claim of the patent concerned.258 Also, the Patent Office may, on
its own initiative, determine whether a substantial new question of
patentability is raised by patents and publications discovered by
the Patent Office or cited by any person.259 Even if a patent or
printed publication was previously considered by the examiner
during the prosecution of the patent, it could still raise a substantial
new question of patentability.260 If the Patent Office determines
that no new substantial question of patentability has been raised by
the cited patent or printed publication, such decision is final and
may not be appealed.261
a) Grounds for Requesting Reexamination
Although the reexamination will be conducted according to the
same standards of patentability as for initial examination, the
issues that can be considered during a reexamination are much
more limited than during the initial examination. They are limited
to “substantial new questions of patentability” that are raised by
the cited prior art and that have not been previously seen by the
examiner.262 And, since the prior art cited for reexamination
256

Id. § 302.
Id. § 302.
258
Id. § 303(a).
259
Id. Such Director-ordered reexaminations are quite rare and are often to address a
public outcry against certain patents. Of the 154 reexaminations ordered by the Director
since 1981, 87% resulted in the patent being revoked or narrowed in scope. See Intell.
Prop. L. Bull., Pfizer Faces Setbacks in Patent Battle over Viagra (Feb. 19, 2004), at
http://www.iplawbulletin.com/cgi-bin/absolutenm/anmviewer.asp?a=986.
260
35 U.S.C. § 303(a).
261
Id. § 303(c).
262
See Whealan, supra note 248, at 43.
257
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purposes can only be patents or printed publications, these issues
must arise from the submitted patents or printed publications.263
The cited prior art can be art that the examiner did not consider
during the initial examination, or art that the examiner considered
previously but not in the same light.264 Typically, the patentability
issues considered during reexamination are limited to 35 U.S.C.
§ 102 (novelty) and § 103 (obviousness).265 Thus, at least
theoretically, if what is claimed in the challenged patent is
unpatentable subject matter under 35 U.S.C. § 101, such as a
perpetual motion machine, the patent cannot be reexamined and
invalidated on that basis.266
b) Participation by Parties
If the Patent Office allows the request for reexamination, and if
the requesting party is not the owner of the challenged patent, the
Patent Office will send a copy of the reexamination request to the
patent owner.267 The patent owner has the option to submit
statements, including amendments or new claims, for consideration
during reexamination.268 Such amendments or new claims must
not enlarge the scope of the patent.269 And if the patent owner
does submit such statements, the requester has an opportunity to
respond to the patent owner’s statements.270 But that is all the
requester can do in an ex parte reexamination—he cannot further

263

35 U.S.C. § 301.
See supra note 260 and accompanying text.
265
See Whealan, supra note 248, at 43. Thus, if the Chinese Viagra patent was
invalidated solely based on enablement/written description issues (and no other grounds
for invalidation were sustainable), under current U.S. law the same patent in the U.S.
probably would not be invalidated.
266
See id. If the new or amended claims proposed by the patent owner during
reexamination are being examined for the first time, the examiner can consider §§ 101
and 112, and any other issues that relate to patentability. See id. at 44. In addition, the
challenger will still have the option of going to court. See id. at 43. This illustrates a
serious limitation of the current U.S. reexamination procedure, given that the
reexamination system was created to provide a cheaper and quicker resolution of a
validity dispute than through District Courts. See id. at 42.
267
35 U.S.C. § 302.
268
Id. § 304.
269
See id. § 305.
270
Id. § 304.
264

SUN

312

1/25/2005 6:16 PM

FORDHAM INTELL. PROP. MEDIA & ENT. L.J.

[Vol. 15:273

participate.271 In fact, a requester rarely gets this limited chance to
participate. Few patent owners would submit statements after
receiving the reexamination order, because doing so would permit
the requester a second chance to attack the patent.272
c) Who Does the Reexamination?
Who at the USPTO conducts the reexamination? Is the task
entrusted to a panel of expert examiners, like those in Japan, the
EPO, or China? Actually none of the above. The USPTO treats
reexamination truly as examination for a second time, and
conducts the reexamination in the same fashion as the patent
application was examined in the first instance.273 But it is said that
the Patent Office does try to do the reexamination faster and more
carefully than an initial application.274 Historically, the examiner
chosen for the reexamination had generally been the examiner who
examined the initial application that issued into the challenged
patent.275 Recently, the USPTO adopted a general policy to assign
the reexamination to an examiner different from the examiner(s)
who examined the initial application.276 Another recent change in
the reexamination practice is that, to enhance the quality of ex
parte reexamination, a “patentability review conference” will be
convened in each ex parte reexamination proceeding (1) just
before issuing a final rejection of claims, and (2) just before

271

See Whealan, supra note 248, at 43.
See id.
273
See 35 U.S.C. § 305 (“[R]eexamination will be conducted according to the
procedures established for initial examination.”); see also Whealan, supra note 248, at
43.
274
See 35 U.S.C. § 305 (“All reexamination proceedings under this section . . . will be
conducted with special dispatch within the Office.”); see also Whealan, supra note 248,
at 43.
275
USPTO, Change in Policy of Examiner Assignment in Ex Parte Reexamiation
Proceedings and Establishment of Patentability Review Conferences in Ex Parte
Reexamination Proceedings, 1237 OG 138 (Aug. 29, 2000), http://www.uspto.gov/web/offices/com/sol/og/2000/week35/patreex.htm.
276
Id. An exception to this general policy will apply if, for example, the original
examiner is the only examiner with adequate knowledge of the relevant technology. Id.
272
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issuing a Notice of Intent to Issue Reexamination Certificate to
confirm or allow claims.277
3. Inter Partes Reexamination
In 1999, the American Inventors Protection Act (AIPA)278
introduced “inter partes reexamination” into the U.S.
reexamination system.279 The biggest difference between ex parte
reexamination and inter partes reexamination is that the latter
allows the requestor to participate in the process and to respond to
everything the patent owner says.280 Also, unlike ex parte
reexamination, the request for inter partes reexamination must
provide the identity of the real party in interest.281
Several aspects of the inter partes reexamination are similar to
those of the ex parte reexamination: any third party can, at any
time, file a request for inter partes reexamination of a patent;282 the
prior art that can be relied upon for inter partes reexamination is
the same as for ex parte reexamination;283 the request must be in
writing and must set forth the pertinence and manner of applying
the cited prior art to every claim for which reexamination is
requested;284 the Patent Office will determine whether the request
raises a substantial new question of patentability affecting any
claim of the patent;285 the reexamination will be conducted
277

Id. The patentability review conference will consist of three members, one of whom
will be the examiner in charge of the reexamination. The other two members will be
examiners, such as Primary Examiners, who are knowledgeable in the technology of the
invention and/or who are experienced in reexamination practice. Id. This seems to be in
part an effort by the USPTO to address the perception that the ex parte reexamination
proceeding is unduly favorable to the patentee. See id.
278
The American Inventors Protection Act of 1999, Pub. L. No. 106-113, 113 Stat.
1537-544 (codified as amended in scattered sections of 35 U.S.C.), available at
http://www.uspto.gov/web/offices/dcom/olia/aipa/index.htm [hereinafter AIPA]. The
AIPA was later amended. Intellectual Property and High Technology Technical
Amendments Act of 2002, Pub. L. No. 107-273, 116 Stat. 1758.
279
The provisions of the AIPA regarding inter partes reexamination are codified in 35
U.S.C. §§ 311–318 (2003).
280
See Whealan, supra note 248, at 47; see also 35 U.S.C. § 314(b).
281
35 U.S.C. § 311(b)(1).
282
See id. § 311(a).
283
See id.
284
Id. § 311(b)(1)–(2).
285
Id. § 312(a).
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according to the procedures established for initial examination;286
the patent owner is permitted to propose non-broadening
amendments and/or new claims;287 and all the proceedings are
conducted with special dispatch.288 Also, neither the requester nor
the patent owner can appeal the Patent Office’s determination of
whether the request raises a substantial new question of
patentability affecting any claim of the patent.289
Regarding the back-and-forth nature of the inter partes
process, any documents filed by either the patent owner or the
requester, except the request for reexamination itself, are served on
the other party.290 In addition, the requester is entitled to receive a
copy of any communication the Patent Office sends to the patent
owner concerning the reexamination.291 Each time the patent
owner files a response to a Patent Office Action on the merits, the
third-party requester will be given one opportunity to file written
comments addressing issues raised by the Office Action or the
patent owner’s response thereto.292
4. Appeal
The patent owner in either an ex parte or an inter partes
reexamination can appeal from any decision adverse to the
patentability of the patent reexamined.293 Such an appeal should
be filed to the Board of Patent Appeals and Interferences
(BPAI).294 If not satisfied with the final decision of the BPAI, the
patent owner can then appeal to the United States Court of Appeals
for the Federal Circuit (CAFC).295
286

Id. § 314(a).
See id. § 314(a).
288
Id. § 314(c).
289
Id. § 312(c). Whereas in an ex parte reexamination proceeding, the statute expressly
prohibits only the requester from appealing a determination that no new substantial
question of patentability has been raised. See supra note 261 and accompanying text.
290
See id. § 314(b)(1) (“With the exception of the inter partes reexamination request,
any document filed by either the patent owner or the third-party requester shall be served
on the other party.”).
291
See id.
292
See § id. 314(b)(2).
293
See id. §§ 306, 315(a)(1).
294
See id. § 134(b).
295
See id. § 141.
287
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Although the requester in an ex parte reexamination does not
have the right to appeal from a decision of the ex parte
reexamination,296 a third-party requester in an inter partes
proceeding may appeal to the BPAI from a final decision favorable
to the patentability of the challenged patent or part thereof.297 And
if the third-party requester is not satisfied with the final decision of
the BPAI, it can then appeal to the CAFC.298
Both the patent owner and the third-party requester are entitled
to be a party to any appeal taken by the other party.299 If, in an
inter partes reexamination, any claim of the challenged patent is
found valid after exhaustion of appeal, the third-party requester
cannot at a later time challenge the validity of such claim in a civil
trial (such as in a District Court) based on any ground that the
third-party requester raised or could have raised during the inter
partes reexamination proceedings.300 This estoppel does not apply,
however, if the assertion of invalidity in the civil trial is based on
newly discovered prior art unavailable to the third-party requester
or the USPTO at the time of the inter partes reexamination.301
Nevertheless, this estoppel is an important concern for third-party
requesters.302

296

The requester is not considered a party to the ex parte reexamination process, and the
statutory provision regarding appeal from a decision in an ex parte reexamination only
provides the patent owner a right to appeal from adverse decisions. See id. § 306.
297
Id. § 134(c).
298
Id. § 141. The AIPA as originally enacted specifically precluded the third-party
requester of the inter partes reexamination from appealing a decision of the BPAI to the
CAFC. See id. § 134(c), amended by AIPA, 113 Stat. 1501A-571. The 2002 amendment
to the AIPA changed this. See Changes to Implement the 2002 Inter Partes
Reexamination and Other Technical Amendments to the Patent Statute, 68 Fed. Reg.
70996 (Dec. 30, 2003), available at http://www.uspto.gov/web/offices/com/sol/og/2004/week03/patchng.htm (last visited Oct. 29, 2004).
299
See 35 U.S.C. §§ 315(a)(2), 515(b)(2). The AIPA as originally enacted did not
permit the third party requester to participate in an appeal taken by the patent owner to
the CAFC. The 2002 amendment to AIPA provided this right to the third-party requester.
See Changes to Implement the 2002 Inter Partes Reexamination and Other Technical
Amendments to the Patent Statute, 68 Fed. Reg. 70996 (Dec. 30, 2003).
300
See 35 U.S.C. § 315(c).
301
See id.
302
See Whealan, supra note 248, at 47.
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5. Outcomes of the Reexamination and Their Effects
In both an ex parte and an inter partes reexamination, when the
time for appeal has expired or any appeal proceeding has
terminated, the Patent Office will issue and publish a certificate
indicating the status of the reexamined patent.303 Any claim of the
patent, including a claim added or amended during reexamination,
could be found either patentable, unpatentable, or patentable as
amended.304 The new or amended claims in a reexamined patent
are enforceable subject to certain third-party intervening rights.305
6. Statistics of Use
It generally takes one to two years to complete an ex parte
reexamination, even though reexamination is given top priority in
the USPTO.306 Interestingly, third parties requested about 55%,
and patent owners about 43%, of the reexaminations.307
A 2001 report revealed that, during the first twenty years after
the inception of ex parte reexamination, there had been on average
about 300 reexaminations per year, which was about 0.2% of the
average 150,000 patents issued each year.308 In recent years, the
fraction of issued patents that have been reexamined is even
smaller than 0.2%.309 There had been a decrease in the number of
reexamination requests since the 1996 CAFC decision in In re
Recreative Technologies Corp.,310 which held that the challenger
of a patent cannot in reexamination rely on art already cited during
initial prosecution of the patent application, even though the art
raises new questions during reexamination.311 This rule has since

303

See 35 U.S.C. §§ 307(a), 316(a).
See id. §§ 307(a), 316(a).
305
See id. §§ 252, 307(b), 316(b).
306
See Whealan, supra note 248, at 44.
307
See id.
308
See id.
309
See USPTO, Performance and Accountability Report Fiscal Year 2003, at
http://www.uspto.gov/web/offices/com/annual/2003/060401_table1.html (last modified
Feb. 13, 2004).
310
83 F.3d 1394 (Fed. Cir. 1996); see also Whealan, supra note 248, at 44.
311
See Whealan, supra note 248, at 45.
304
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been preempted by the November 2002 amendments of the AIPA,
as embodied in 35 U.S.C. § 303(a).312
Of the reexamined patents at the USPTO, about 26% were
maintained unchanged, about 10% are revoked in full, and about
64% are maintained after some amendments.313 The requests for
reexamination seem to spread evenly across different technological
areas.314
The inter partes reexamination has been scarcely used since its
inception in November 1999. From that time until November
2002, it has been used only four times.315 One proposed
explanation for this is that there had not been many patents eligible
for inter partes reexamination—it takes about two years for a
patent to issue and inter partes reexamination applies only to
patents filed and issued after November 29, 1999.316 Now that
more time has passed, are we seeing a different picture?
During the first twelve weeks of 2004, the USPTO Official
Gazette published seventy-seven requests for ex parte
reexamination, but only six requests for inter partes
reexamination.317 Interestingly, twenty-two of the seventy-seven
ex parte reexamination requests—nearly 30%—could have been
filed as inter partes reexamination, because the patents concerned
were filed after November 29, 1999.318 The rarity of inter partes
reexamination, therefore, may not be explained by the fact that
only patents filed and issued after November 29, 1999 are eligible
for inter partes reexamination. If the inter partes reexamination
procedure does not encourage third parties to file requests for
reexamination (relative to the ex parte procedure), then the

312

Pub. L. No. 107-273, § 13105, 116 Stat. 1900 (codified as amended by 35 U.S.C. §
303(a) (2002)); see also supra notes 260, 264 and accompanying text.
313
See Whealan, supra note 248, at 45.
314
See id.
315
See FTC Report, supra note 17, ch. 5, at 16.
316
See Whealan, supra note 248, at 47.
317
See USPTO, Official Gazette Notices for 2004, http://www.uspto.gov/web/offices/com/sol/og/2004/2004.htm (last visited Oct. 29, 2004).
318
See id.
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introduction of inter partes reexamination will not result in an
increase in the overall usage of the reexamination procedure.319
IV. CHINA’S POST-GRANT INVALIDATION SYSTEM IN COMPARISON
WITH THOSE OF THE TRILATERAL OFFICES
In today’s patent world, many patents are of poor quality and
are invalid.320 In the United States, for example, great concern has
been raised about the number of questionable patents issued.321 It
is reported that the USPTO approves as many as 97% of the
applications placed before it.322 Patents for “business methods”
implemented in software are frequently of very poor quality,
because patents in this area are routinely issued overlooking
clearly anticipating prior art.323 Biotech firms, while regarding
patents as the basis for their industry, are concerned that overbroad
patents may discourage further innovation in biotechnology.324
Budgetary limitations, an exploding filing rate, and the expanding
range of patentable subject matter are cited as reasons for the
decline in the quality of U.S. patents.325 This problem, however, is
not unique to the U.S.; the JPO and EPO, for example, are facing
equally challenging circumstances.326 The fact that about twothirds of the opposed patents in the EPO were either revoked in full
or amended underscores the concern about patent quality.327
319
An estimation based on the data from the Official Gazette Notices for 2004 suggests
that there will be over 300 requests for reexamination in 2004, a number not too far from
the recent average of about 250 requests per year. See id.
320
See Scott R. Boalick, Patent Quality and the Dedication Rule, 11 J. INTELL. PROP. L.
215, 240 (2004).
321
See FTC Report, supra note 17, Executive Summary, at 5.
322
See John R. Thomas, The Responsibilities of the Rulemaker: Comparative
Approaches to Patent Administration Reform, 17 BERKELEY TECH. L.J. 727, 728 (2003)
(citations omitted).
323
See Robert P. Merges, As Many as Six Impossible Patents before Breakfast: Property
Rights for Business Concepts and Patent System Reform, 14 BERKELEY TECH. L.J. 577,
589 (1999).
324
See FTC Report, supra note 17, Executive Summary, at 5 n.16.
325
See Thomas, supra note 322, at 728.
326
See id. at 728–29.
327
See supra Part III.B. The situation in the United States is similar: only 26% of the
reexamined patents were maintained unchanged. See supra note 313 and accompanying
text.
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The poor quality of patents makes a functional post-grant
invalidation procedure extremely important. The examination of a
patent application is essentially an ex parte process in the Patent
Offices, involving only the applicant and the Patent Office.328 It is
unrealistic to expect that the examiner will always have all the
relevant information or knowledge for a proper examination of the
patent application.329 Third party competitors in the same field as
the applicant, however, may have the best information and
expertise, as well as the incentive, to assist in the evaluation of a
patent application.330 Thus, third party participation in the
patenting process will help improve patent quality. However, to
avoid delays in the grant of patents and to prevent harassment of
patent applicants, the procedure for challenging a patent should be
after the patent issues.331
The purpose of a post-grant patent invalidation system is to
provide an efficient, cost-effective, and reliable mechanism for
third parties to challenge a granted patent, thereby improving the
quality of patents. To achieve this goal, an invalidation system
should (i) allow challenges to a patent right to be based on any
issues concerning patentability,332 (ii) allow full participation of
the third-party challenger, (iii) employ a highly-qualified panel for
reexamination, and (iv) provide a valid decision in a timely
manner. Obviously, balancing would be needed among some of
these aspects, such as between time limits and the extent to which
the parties involved are allowed to fully present their arguments
and evidence.
Against the backdrop of such a desired system, how does
China’s invalidation system, or that of the USPTO, EPO or JPO,
measure up? In Table 1, several key aspects of China’s current
patent invalidation system are compared with those of the trilateral

328

See FTC Report, supra note 17, Executive Summary, at 9.
See id.
330
See FTC Report, supra note 17, Executive Summary, at 8.
331
See id. Consistent with this principle, both China and Japan have abolished their pregrant revocation procedures in the 1990s. See supra Parts II, III.A.
332
The position of the U.S. Federal Trade Commission is that “[a]t a minimum, patent
challengers should be able to raise issues of novelty, nonobviousness, written description,
enablement, and utility.” See FTC Report, supra note 17, Executive Summary, n.26.
329
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offices.333 A more in-depth discussion of the practices in the four
Patent Offices is presented below. This analysis focuses on
grounds for requesting invalidation, participation by third-party
requester, expertise of the reexamination panel, efficiency, and
frequency of usage.
A. Grounds for Challenging a Patent
In China, challenges to the validity of a patent may be based on
any grounds concerning patentability.334 This is commensurate
with, if not broader than, the scope of allowable grounds in the
JPO and the EPO, but is clearly much broader than the limited
grounds permissible in the United States (i.e., novelty and
obviousness).335 Moreover, similar to the JPO and EPO practice,
in SIPO prior art disclosure of the invention could be “by any
way,”336 in contrast to the U.S. requirement that only patents or
printed publication can be prior art for post-grant invalidation
purposes.337
With respect to novelty under Chinese Patent Law,338
“disclosure” includes disclosure by publication and nonpublication disclosure.339
Publication disclosure refers to
disclosure in the form of printed or typed paper documents, film,
tape, CD-ROM, photograph, etc.340 Non-publication disclosure
refers to disclosure by various forms other than publication, such
333

See supra Parts II–III.
See supra Part II.B.
335
See Japan Patent Law, supra note 167, § 123.1; EPC, supra note 194, art. 100; 35
U.S.C. § 102 (2003).
336
See EPC, supra note 194, art. 54(2) (“The state of the art shall be held to comprise
everything made available to the public by means of a written or oral description, by use,
or in any other way, before the date of filing of the European patent application.”)
(emphasis added); see also supra Part III.A–B.
337
35 U.S.C. § 301 (2003).
338
See Chinese Patent Law, supra note 27, art. 22.2 (“Novelty means that, before the
date of filing, no identical invention or utility model has been publicly disclosed in
publications in the country or abroad or has been publicly used or made known to the
public by any other means in the country . . . .”) (emphasis added).
339
See Guidelines, supra note 42, pt. IV, ch. 1, § 12; pt. II, ch. 3, § 2.1.3 (“Methods of
Disclosure: The methods of disclosure include disclosure by publications, disclosure by
use and disclosure by other methods.”).
340
See id. pt. II, ch. 3, § 2.1.3.1 (“Disclosure by Publication”).
334
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as use disclosure,341 oral disclosure,342 and disclosure by nonpublication carrier.343
To improve patent quality, such a broad definition of disclosure
is critical. In performing a substantive examination of a patent
application, it is far more difficult for the examiner to be aware of
technology disclosed by use or known to the public through
methods other than publication or patents. The prior art before the
examiner mainly refers to technology disclosed in publications or
patents.344 Thus, allowing the third party challenger to attack the
validity of a patent based on issues of patentability arising from
non-publication art is an important feature of an effective postgrant invalidation procedure. Of course, a third-party requester
should be required to make a suitable threshold showing of
material issues regarding patentability.345
B. Participation by Third-Party Requester
Given the value a third-party requester may add to the
patenting process, a post-grant invalidation system should allow
ample opportunity for the third-party requester to participate in the
reexamination process. In the SIPO, as well as in the EPO and the
JPO, the invalidation proceedings are inter partes in nature, and
the third-party requester is given ample opportunity for
participation, such as through oral proceedings.346 “The EPO has
long recognized the inadequacies in simply assigning to third
parties the role of informant or amicus curiae and then leaving it to
the Patent Office to use the [cited prior art] material as it sees fit.
Rather, the European Patent Convention (EPC) grants full party
status to such participants, thus giving them some control on the
way the material they provide is handled.”347 In the JPO, the
invalidation proceeding is literally called a “trial,”348 in effect
341

See id. pt. IV, ch. 1, § 12.2.5 (“Use Disclosure”).
See id. pt. IV, ch. 1, § 12.2.6 (“Oral Disclosure”).
343
See id. pt. IV, ch. 1, § 12.2.7 (“Disclosure by Non-publication Carrier”).
344
See id. pt. II, ch. 3, § 2.3.
345
See FTC Report, supra note 17, Executive Summary, at 8.
346
See supra Parts II–III.
347
See Arriola, supra note 220.
348
See generally Japan Patent Law, supra note 167, ch. VI, § 123 (referring to
invalidation proceedings as “trials”).
342
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granting the requester full-party status.349 A requester enjoys a
similar status in an invalidation proceeding in the SIPO.350
In the USPTO, patent reexamination can be either an ex parte
or an inter partes procedure.351 In an ex parte reexamination,
third-party participation is extremely limited. Besides the filing of
a reexamination request, a third-party requester’s only other
opportunity for participation is to respond to the patent owner’s
statements in response to the reexamination request.352 In reality,
the third party rarely gets even this limited opportunity for
participation because patent owners typically do not submit
statements in response to the reexamination request.353 In response
to this widely criticized limitation of ex parte reexamination, inter
partes reexamination was introduced by the AIPA in 1999.354 A
third-party requester in an inter partes reexamination can
participate in the reexamination and respond to everything the
patent owner says by filing written comments.355
All the post-grant invalidation procedures of China, the EPO
and Japan allow oral proceedings involving both the requester and
the patent owner.356 In China, as in the JPO and the EPO, oral
proceedings are ordered either at the request of the parties, or
based upon the need of the case as determined by the
Reexamination Board.357 Also, the oral proceedings are held
publicly.358 In the USPTO, however, the reexamination is treated
as another patent application examination,359 and would therefore
be ex parte in nature (except that in an inter partes reexamination,
the third-party requester may participate through filing written

349

See supra Part III.A.
See supra Part II.D.
351
See supra Part III.C.
352
See supra notes 270–71 and accompanying text.
353
See supra note 272 and accompanying text.
354
See supra note 279 and accompanying text.
355
See supra notes 280, 290, 292 and accompanying text.
356
See supra Parts II–III.
357
See supra notes 109 (China), 172 (JPO), 216 (EPO) and accompanying text.
358
See supra notes 96, 111. For the EPO, see supra note 224. In the JPO, an oral
proceeding is generally the format of the invalidation trial. See supra note 172 and
accompanying text.
359
See supra note 273 and accompanying text.
350
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submissions360). Hence, even if there is an interview, it would not
be open to the public, and the third-party requester would not be
allowed to participate.
C. Expertise of the Reexamination Panel
Just as the expertise of the patent examiner affects the quality
of the initial examination of a patent application, the expertise of
the reexamination panel in a patent invalidation case affects the
quality of the reexamination. The quality of reexamination in turn
affects the usage of the invalidation system. Typically, only
patents that are economically important are challenged. Because
of the economic consequences at stake for both the patentee and
the third party requester, it makes sense to entrust the role of
reexamining the challenged patents to highly-experienced
examiners in order to ensure a reliable determination of the validity
of the challenged patents.
The composition of China’s reexamination panel is similar to
those of the EPO and the JPO. China’s Patent Reexamination
Board consists of experienced technical and legal experts of the
SIPO.361 To further ensure the quality of the reexamination, cases
involving great economic interests and/or important legal issues
are examined by a three- to five-member panel.362 An examiner
who was involved in the initial examination of the application
leading to the challenged patent cannot serve on the reexamination
panel.363 Similar collegiate panels are used in the EPO (typically a
three-member panel of technical examiners, which can be enlarged
by the addition of a legally qualified examiner)364 and the JPO (a
three-member panel of examiners with at least ten years of patent
examination experience).365 Also, to ensure the quality and
fairness of the reexamination (opposition), the EPC requires that
360

See supra notes 290–92 and accompanying text.
See supra note 84 and accompanying text.
362
See supra notes 85–89 and accompanying text. Simple cases, typically not involving
invention patents, can be examined by a sole examiner. See supra note 85 and
accompanying text.
363
See supra note 90 and accompanying text.
364
See supra note 216 and accompanying text.
365
See supra note 175 and accompanying text.
361
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the Chairman, the optional legal examiner, and at least two of the
three technical examiners of the Opposition Division must not
have taken part in the proceedings for grant of the patent.366 In the
JPO, the invalidation trial is handled by the Board of Appeals and
Trials, instead of by the examiner who initially approved the
patent.367
In contrast, again, the USPTO adopts a different approach: a
single examiner conducts the reexamination instead of a panel of
examiners368 (although, in an ex parte reexamination, a
“patentability review conference” just before issuing a final
decision has been recently introduced369). Other than familiarity
with the claimed subject matter of the patent, there is no special
requirement regarding the qualifications of the single examiner
undertaking the reexamination. A recent policy, however, does
require, with exceptions, that the examiner not be the same
individual who originally allowed the patent application.370 While
the examiner chosen for the reexamination is supposed to perform
the reexamination more carefully than he or she examines an initial
application,371 there still exists a concern that reexamination
unduly favors the patentee.372
D. Efficiency/Timeliness
One of the problems with China’s post-grant invalidation
system is that it takes up to two years for the Reexamination Board
to issue a decision.373 In China, reevaluation of the validity of a
granted patent is the sole province of the SIPO Patent
Reexamination Board.374 The Chinese Patent Law does not
provide a mechanism to accelerate the invalidation proceedings
when litigation is pending in a People’s Court.375 Although the
366
367
368
369
370
371
372
373
374
375

See supra note 216 and accompanying text.
See supra note 173 and accompanying text.
See supra note 273 and accompanying text.
See supra note 277 and accompanying text.
See supra note 276 and accompanying text.
See supra note 274 and accompanying text.
See FTC Report, supra note 17, Executive Summary, at 16.
See East IP Group, supra note 58.
See supra note 120 and accompanying text.
See id.
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People’s Courts have discretion in whether to stay the litigation
when an invalidation proceeding is pending in the SIPO, such a
stay is not common in cases involving invention patents.376 A
patent found infringed by a People’s Court may be later declared
invalid by the SIPO Patent Reexamination Board and the SIPO’s
invalidation decision will not have retroactive effect.377 Thus, the
Chinese post-grant invalidation system can be improved by
providing mechanisms to speed up the invalidation process and to
stay a litigation in court once an invalidation request is made in
SIPO.378 Corresponding rules can also be enacted to deter undue
delay and harassment via invalidation requests.
The average time the USPTO takes to grant a patent is about
two years.379 Although reexamination is given top priority in the
USPTO, it generally takes one to two years to complete an ex parte
reexamination.380 One can expect that an inter partes
reexamination would probably take longer than an ex parte
reexamination due to the participation of the third-party requester.
The duration of an invalidity trial in the JPO does not differ
significantly from that of the SIPO or the USPTO. The JPO’s goal
is to conclude invalidation trials within fifteen months.381
The EPO, however, takes longer to conclude an opposition. It
is estimated that the entire opposition process, including appeals,
may take up to five years or more.382 The delay is largely because
376
See supra note 124 and accompanying text. It is likely that invalidation requests
involving invention patents are resolved more quickly by the Patent Reexamination
Board because such patents (but not utility model or design patents) have been
substantively examined before grant. Thus, delays by an accused infringer of an
invention patent, through requesting an invalidation proceeding, are rarer than in cases
involving infringement of utility model or design patents. See Louis S. Sorell, A
Comparative Analysis of Selected Aspects of Patent Law in China and the United States,
11 PAC. RIM L. & POL’Y J. 319, 334 (2003).
377
See supra notes 117, 121 and accompanying text.
378
An example of such a stay of litigation in the U.S.: a federal judge in the District
Court for the District of Delaware has put on hold the lawsuit filed by Pfizer against Eli
Lilly and Icos Corp. for alleged infringement of its Viagra patent while the USPTO
reexamines the Viagra patent. See Pfizer Faces Setbacks in Patent Battle over Viagra,
supra note 259.
379
See supra note 309.
380
See supra note 306 and accompanying text.
381
See supra note 174 and accompanying text.
382
See Arriola, supra note 220.
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the Opposition Division desires to give each party the full
opportunity to present its comments on all important issues and to
take account of every relevant document, argument, or piece of
evidence, even if they are submitted late.383 Thus, to make a postgrant invalidation procedure a true alternative to costly and lengthy
litigation, it is critical to balance the quality and efficiency of the
post-grant reexamination process.384
E. Frequency of Usage/Popularity
“No post-grant [patent invalidation] procedure will be
successful unless it is used.”385 As Table 1 shows, the frequency
of the usage of the SIPO invalidation procedure, at about 2%, is
low when compared to that of the EPO and the projected rate of
usage of the invalidation trial at the JPO.386 The reason for this
lower rate of use, however, may at least in part have to do with
China’s still developing IPR system and the public’s still growing
consciousness of IPR protection. With both the number of patent
grants and the number of patent infringement suits growing rapidly
each year, it would not be surprising to see an increase over time in
the percentage of granted patents that are subject to invalidation
challenges.
The EPO opposition procedure is the most frequently used
among the invalidation systems of the four Patent Offices, with a
rate of 6–8% of granted patents.387 Despite the length of time it
takes for a final decision, the EPO opposition procedure is
preferred over individual national proceedings because the
opposition decision will have effect in all designated States.388
Moreover, the EPO panel conducting the opposition consists of
members who are technically-qualified, as compared to judges

383

See id.; see also supra notes 220–23 and accompanying text.
Despite the relatively lengthy EPO opposition procedure, it is the mostly heavily
used patent invalidation process among the four patent offices, largely due to the effect of
an EPO opposition decision in all designated member states. See infra Part IV.E.
385
See FTC Report, supra note 17, Executive Summary, at 20.
386
See supra note 144 and accompanying text.
387
See supra notes 143, 190, 244, 308–09 and accompanying text.
388
See Arriola, supra note 220; see also supra note 231 and accompanying text.
384
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who preside over national proceedings and are essentially trained
only in the law.389
Interestingly, one commentator further observes that:
[D]ifferent attitudes regarding the use of the opposition
procedure may affect its eventual use by a third party. On
the one hand, companies based in countries which have
long been familiar with opposition procedures, e.g.
Germany, view opposition as an extension of examination
in order to limit a competitor’s right while involving only a
reasonable amount of effort. Consequently, the procedure
is viewed not as an act of aggression but rather as a method
of defining a competitor’s territory. . . . On the other hand,
a different attitude is evident by companies based in other
countries where oppositions were not the norm prior to
joining the EPC. Because such parties view opposition as
tantamount to legal action or an act of aggression against
the patentee, their use of the opposition procedure is
minimal.390
According to this observation, one might expect that the same
EPO opposition system would be used less frequently in China and
Japan, where people have been considered to be traditionally less
litigious than Western people.391
The JPO trial for invalidity is expected to be used fairly
frequently, at about 4%, based on past experiences with the
previous post-grant opposition and invalidation procedure.392
The reexamination procedure of the USPTO, in stark contrast
with that of the EPO, shows a strikingly low frequency of use, with
less than 0.2% of the granted patents subjected to reexamination.393
Moreover, the patent owner files 43% of the reexamination

389

See Arriola, supra note 220.
See id.
391
See, e.g., FRANK K. UPHAM, LAW AND SOCIAL CHANGE IN POSTWAR JAPAN 1, 299 n.1
(1987). Both the Chinese and Japanese societies are deeply influenced by the Confucian
ideals of social harmony. See id. at 1.
392
See supra note 190 and accompanying text.
393
See supra notes 308–09 and accompanying text.
390
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requests.394 The main reason for this low usage seems to lie in the
U.S. reexamination system itself, rather than with any cultural
explanation.
There are numerous roadblocks for a third-party requester of
patent reexamination in the U.S., including, as discussed above,
very limited grounds for reexamination, no oral proceedings for the
third-party requester, and the need to reveal the identity of the
party of true interest requesting an inter partes reexamination.395
Additionally, the estoppel rule prohibiting a third-party requester
from using the same art in later litigation has significant deterring
effect.396 Another factor disfavoring reexamination may be that
third-party challengers lack confidence in the system because it
does not employ a panel of highly experienced examiners for the
reexamination. Thus, third-party competitors in the U.S. may
choose to challenge the patent’s validity in courts, but only if they
are allowed to do so by the patent owner, i.e., after being sued by
the patent owner for infringement.397 And if litigation does occur,
it typically costs millions of dollars and takes years to resolve.398
The above comparative analysis indicates that, while the postgrant patent invalidation system in China is similar to those of the
EPO and the JPO in most aspects, it is very different from that of
the USPTO, which has not been successful, as evidenced by its
conspicuously low frequency of use. There have been numerous
proposals for reforming the U.S. reexamination system (including
the new inter partes reexamination) towards an administrative
system that resembles those of the EPO, JPO, as well as SIPO.399

394

See supra note 307 and accompanying text.
See supra note 281 and accompanying text.
396
See supra notes 300–02 and accompanying text.
397
See FTC Report, supra note 17, Executive Summary, at 6.
398
See id.
399
See generally FTC Report, supra note 17, ch. 5, pt. III; USPTO, 21st Century
Strategic Plan, Post-Grant Review of Patent Claims (Apr. 2, 2003),
http://www.uspto.gov/web/offices/com/strat21/action/sr2.htm (last visited Oct. 29, 2004);
Janis, supra note 17; Kristen Jakobsen Osenga, Rethinking Reexamination Reform: Is it
Time for Corrective Surgery, or Is it Time to Amputate?, 14 FORDHAM INTELL. PROP.
MEDIA & ENT. L.J. 217 (2003); Mossinghoff & Kuo, supra note 150; Allan M. Soobert,
Breaking New Grounds in Administrative Revocation of U.S. Patents: A Proposition for
Opposition—and Beyond, 14 SANTA CLARA COMPUTER & HIGH TECH. L.J. 63 (1998).
395

SUN

2004]

1/25/2005 6:16 PM

POST-GRANT PATENT INVALIDATION

329

Obviously, if a global patent system is ever to become a reality,400
the U.S. patent reexamination system must come closer to the
practice of the rest of the world.
CONCLUSION
Patent law must strike a delicate balance between granting
monopoly rights to inventors and protecting the public from the
anti-competitive effects of monopolies.401 A functional post-grant
patent invalidation system that improves the quality of patents is
one of the best means for achieving this balance.402 In an effort to
improve its economy and to comply with the TRIPS requirements
as a member of the WTO, China has been actively improving its
patent law system, including the post-grant patent invalidation
procedure.
For those who are unfamiliar with the development and current
status of China’s IP law and practice, it may come as a surprise
that the Chinese post-grant patent invalidation system closely
resembles the relatively successful invalidation procedures of the
European Patent Convention and Japan.403 The recently adopted
practice of posting detailed decisions on the Internet has increased
the transparency of judicial resolution of IPR cases, including

400
A global patent system is now a 120-year dream. See Michael N. Meller, Planning
for a Global Patent System, 80 J. PAT. & TRADEMARK OFF. SOC’Y 379, 379 (1998).
401
See Arriola, supra note 220.
402
See id.
403
It will be less of a surprise if the reader learns about the serious effort the Chinese
have taken to set up and improve their IP system. For example, to figure out how to
construct its first Patent Law of March 12, 1984, China dispatched delegations to major
industrial nations, including the United States, West Germany, and Japan; to relatively
prosperous socialist states such as Romanian and Yugoslavia; and to major international
intellectual property organizations such as the World Intellectual Property Organization
(WIPO) and the UN Education, Science and Cultural Organization. See ALFORD, supra
note 18, at 69. “The full patent laws of some 35 jurisdictions were translated and those of
more than 100 other nations summarized,” the experience of Hong Kong was studied,
and inside China, the views of cadres in factories, scientific research institutes,
universities and government agencies were solicited. Id. “In the end, the drafting
committee spent more than five years, during which it went through some 20 drafts prior
to finally producing a bill,” which was passed only after the National People’s Congress
(NPC) further amended it. Id.
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appeals from SIPO’s patent invalidation decisions.404 These may
be reasons to have more confidence in a fair resolution of Pfizer’s
pending appeal of the invalidation of the Viagra patent.
Regardless of the outcome of the appeal, an important lesson from
the Viagra case is that, in anticipation of likely challenges to the
validity of economically significant patents, multinational
companies should understand the law and practice of the Chinese
post-grant patent invalidation system, and adopt best practices in
the acquisition and maintenance of patent rights in China.

404

See supra note 13 and accompanying text.
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TABLE 1. KEY FEATURES OF POST-GRANT PATENT INVALIDATION
SYSTEMS IN CHINA AND THE TRILATERAL PATENT OFFICES

China

Japan

EPO

U.S.

Requester

Any
person

Any person

Any person
except patent
owner

Any person

ID of true
party in
interest

No

No

No

Yes if inter
partes

Time for
request

Any time
after grant

Any time
after grant,
even after
patent
expires

Within 9
months of
grant, even if
patent lapsed

Any time
after grant

Requester
participation

Inter
partes

Inter partes

Inter partes

Ex parte &
limited inter
partes

Oral
proceeding

Conducted
per party’s
request or
Board
discretion;
public

Oral
proceeding
is the
general
format

Conducted per
party’s request
or Division
discretion;
public

Mostly documentary
proceeding,
as in initial
examination

Almost any
ground on
which a
patent can
be found
invalid

novelty,
inventive step,
utility, subject
matter, insuff.
disclosure,
inappr. extn. of
protection
scope, pub.
interest,
morality

Typically
§§ 102 &
103 issues
based on
patents,
printed
publications

Grounds
for request

Any
ground on
which a
patent can
be found
invalid
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Sole
member
or 3-5
member
panel of
highly
experienced
examiners
not
involved
in initial
examination
Both
requester
and
patentee
within 3
months
~ 2 years
Frequent,
~ 2%
(relative
to # of
patent
grants)
China

[Vol. 15:273

3-member
panel;
highly
experienced and
qualified
examiners
not
involved in
initial
examination

3-member
Division of
technical
examiners;
enlargeable by
a legal
examiner;
limited role by
initial
examiner

One regular
examiner,
according to
procedures
established
for initial
examination

Both
requester
and
patentee,
within 90
days

Both requester
and patentee,
within 2
months

Patentee;
requester
only if inter
partes

Goal: 1215 months

5 or more
years, if incl.
appeal

Expected
to be
frequent
(~ 4%)

Frequent, ~ 68%

Japan

EPO

special
dispatch; ~
1-2 years
Very
infrequent,
especially
inter partes
(< 0.2% for
ex parte)
U.S.

